Top 100 Companies in the Biopharma space
MedaSystems makes it easy for life science companies and health care providers to collaborate on requests for access to experimental therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Derm-Biome is a biopharmaceutical company that develops and distributes novel skincare therapies to individuals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biomed is a California-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative disorders.
Business Model: unknown
Revenue: 16M
Employees: 120
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
D2team is a group of scientists that specializes in drug discovery and development. D2team is based in Leiden, Zuid Holland.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
International Drug Development is a regulatory affair and development strategy consultancy firm. The company was founded in 2003 and is based in Paris, France.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Cllio engages in developing regenerative medicine using multi-lineage differentiating stress enduring cells.
Business Model: unknown
Revenue: 30.5M
Employees: 419
Industry: Biopharma
Bionavigen is a biopharmaceutical navigation company specializing in consulting for the discovery, preclinical development, translational, and regulatory sciences as well as early development of new drugs through smart acquisition.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Senses Pharmaceuticals specializes in ophthalmic aids and solutions. The company was founded in 2009 and is based in Bangalore, India.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
ASC Therapeutics is a biotechnology company that focuses on discovering and developing cures for intractable diseases. The company was founded in 2008 and is based in Milpitas, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Novavax is a Maryland-based biotechnology company that researches, develops and commercializes vaccines for the treatment of infectious diseases.
Business Model: unknown
Revenue: 1.8B
Employees: 1.5k
Industry: Biopharma
ReCode is a California-based genetic medicines firm that researches and develops novel therapeutics for the treatment of cancer, CNS and cystic fibrosis.
Business Model: unknown
Revenue: 6M
Employees: 70
Industry: Biopharma
CAMP4 is a Massachusetts-based biotechnology company that develops and commercializes RNA therapeutics for the treatment of muscle and heart diseases.
Business Model: unknown
Revenue: 5.1M
Employees: 50
Industry: Biopharma
Epizyme is a Massachusetts-based biopharmaceutical company that develops and commercializes novel epigenetic medicines for the treatment of cancer.
Business Model: unknown
Revenue: 53M
Employees: 250
Industry: Biopharma
Tonix is a New Jersey-based biopharmaceutical company that researches and develops small molecules-based therapeutics for the treatment of CNS disorders.
Business Model: unknown
Revenue: 2M
Employees: 60
Industry: Biopharma
CureVac is a Germany-based biopharmaceutical company that develops and commercializes mRNA therapies for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 132.1M
Employees: 900
Industry: Biopharma
Ginkgo Bioworks is a Massachusetts-based horizontal platform that offers solutions including cell programming and therapeutics discovery for the pharmaceutical sector.
Business Model: unknown
Revenue: 359.5M
Employees: 640
Industry: Biopharma
Scholar Rock is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and neuromuscular disorders.
Business Model: unknown
Revenue: 37.2M
Employees: 140
Industry: Biopharma
Roivant is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases.
Business Model: unknown
Revenue: 18.9M
Employees: 860
Industry: Biopharma
Healx is a biotechnology company that develops an AI drug discovery platform for the treatment of patients with genetic diseases.
Business Model: unknown
Revenue: 1M
Employees: 15
Industry: Biopharma
Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. We built our Integrated Drug Creation™ Platform to identify novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. Biotech and pharma innovators partner with us to create the next generation of protein-based drugs, including Bionic Proteins™ containing nonstandard amino acids, and other novel drug designs that may be impossible to make with other technologies. Our goal is to enable the development of better medicines by Translating Ideas into Drugs™. For more information visit www.absci.com.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 90
Industry: Biopharma
Evotec is a Germany-based pharmaceutical company that develops and commercializes therapies for the treatment of cancer, metabolic and infectious diseases.
Business Model: unknown
Revenue: 724.6M
Employees: 4.5k
Industry: Biopharma
89bio is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of liver and metabolic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
CRISPR is a gene-editing company that develops and commercializes gene-based medicines for the treatment of serious diseases.
Business Model: unknown
Revenue: 2M
Employees: 473
Industry: Biopharma
Datavant is a California-based AI platform that offers solutions such as clinical data management and analytics for industries including life sciences and medical devices.
Business Model: unknown
Revenue: 8.5M
Employees: 250
Industry: Biopharma
nference is an Augmented Intelligence-based platform that provides molecular analytics and clinical insights for the biopharmaceutical sector.
Business Model: unknown
Revenue: 5M
Employees: 115
Industry: Biopharma
InventisBio is a biotech company that researches and develops small molecule drugs for oncology and metabolic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.
Business Model: unknown
Revenue: 517.2M
Employees: 1.3k
Industry: Biopharma
Zenas is a Massachusetts-based biopharmaceutical company that researches and develops immuno-therapeutics for the treatment of autoimmune and rare diseases.
Business Model: unknown
Revenue: 6M
Employees: 56
Industry: Biopharma
Cytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases.
Business Model: unknown
Revenue: 148.2M
Employees: 250
Industry: Biopharma
Prellis is a California-based biotechnology firm that develops and supplies 3D printed lymph nodes drug discovery and development systems for the healthcare industry.
Business Model: unknown
Revenue: 2M
Employees: 35
Industry: Biopharma
Arcellx is a Maryland-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 80
Industry: Biopharma
BrightInsight is a California-based IoT platform that provides patient engagement analytics and dashboard solutions for biopharma and healthcare sectors in the USA and Europe.
Business Model: unknown
Revenue: 37M
Employees: 250
Industry: Biopharma
LatchBio is a California-based cloud platform that enables scientists to store, transform and visualize bioinformatics data.
Business Model: unknown
Revenue: 1M
Employees: 12
Industry: Biopharma
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.
Business Model: unknown
Revenue: 21.9M
Employees: 88
Industry: Biopharma
Halo Labs is a California-based life science instrumentation firm that develops biopharmaceutical formulation and quality control devices for the healthcare sector.
Business Model: unknown
Revenue: 16M
Employees: 40
Industry: Biopharma
ARS is a clinical-stage pharmaceutical firm that develops intranasal epinephrine spray for the treatment of allergic reactions.
Business Model: unknown
Revenue: 2M
Employees: 16
Industry: Biopharma
Geron is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 1.3M
Employees: 70
Industry: Biopharma
VIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases.
Business Model: unknown
Revenue: 284.4M
Employees: 440
Industry: Biopharma
Paige is a New York-based healthtech platform that allows pathologists to treat and diagnose cancer and infectious diseases in prostate biopsies.
Business Model: unknown
Revenue: 7.7M
Employees: 147
Industry: Biopharma
Solugen&s;s mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale. Solugen&s;s patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Berkeley Lights is a California-based digital cell biology company that develops and commercializes cellular therapies and biopharmaceuticals for the healthcare sector.
Business Model: unknown
Revenue: 87M
Employees: 290
Industry: Biopharma
Inotiv is an Indiana-based biopharmaceutical company that offers services such as toxicology, bioanalysis and consulting for the healthcare sector.
Business Model: unknown
Revenue: 547.7M
Employees: 550
Industry: Biopharma
Tessera is a Massachusetts-based biotechnology company that develops and commercializes genome-based therapeutics for the treatment of genetic diseases.
Business Model: unknown
Revenue: 5M
Employees: 250
Industry: Biopharma
La Jolla Pharmaceutical is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of infectious diseases.
Business Model: unknown
Revenue: 55.7M
Employees: 70
Industry: Biopharma
CytoReason is an Israel-based AI platform that offers solutions such as drug discovery and development for pharmaceutical and biotechnology industries.
Business Model: unknown
Revenue: 2M
Employees: 100
Industry: Biopharma
Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.
Business Model: unknown
Revenue: 12.2B
Employees: 10.5k
Industry: Biopharma
Virpax Pharmaceuticals is a Pennsylvania-based biopharmaceutical company that develops non-addictive opioid compounds for pain management.
Business Model: unknown
Revenue: 0 - 100000
Employees: 7
Industry: Biopharma
HotSpot is a Massachusetts-based biotechnology company that develops and commercializes small molecule drugs for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 4M
Employees: 40
Industry: Biopharma
Cellectis is a France-based biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 22.2M
Employees: 294
Industry: Biopharma
Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Aurinia focuses on the development and commercialization of novel drug products for the treatment of lupus nephritis.
Business Model: unknown
Revenue: 129M
Employees: 300
Industry: Biopharma
REGENXBIO research and develops adeno-associated viral gene therapies for treatment of lysosomal storage disorders and ocular diseases.
Business Model: unknown
Revenue: 483.4M
Employees: 370
Industry: Biopharma
Day One is a San Francisco-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 70
Industry: Biopharma
Humanigen is a biopharmaceutical company that develops and commercializes monoclonal antibody therapeutics for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 3.1M
Employees: 10
Industry: Biopharma
Navidea researches and develops precision immunodiagnostic agents and immunotherapeutics for the treatment of cancer and cardiovascular diseases.
Business Model: unknown
Revenue: 211.8k
Employees: 10
Industry: Biopharma
Evofem is a California-based biopharmaceutical company that develops and commercializes contraceptive products for the treatment of reproductive disorders in women.
Business Model: unknown
Revenue: 20.2M
Employees: 119
Industry: Biopharma
Mineralys Therapeutics is a Pennsylvania-based clinical-stage biopharmaceutical that develops and commercializes novel therapeutics for the treatment of hypertension.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
ITM is a Germany-based biotechnology company that develops and supplies therapeutic radiopharmaceuticals and radioisotopes for the treatment of cancer.
Business Model: unknown
Revenue: 15M
Employees: 160
Industry: Biopharma
Oxford Nanopore is an England-based biotechnology company that provides solutions including gene analysis, DNA sequencing and testing for medical research centers.
Business Model: unknown
Revenue: 180.4M
Employees: 705
Industry: Biopharma
Galectin is a Georgia-based biotechnology company that develops and commercializes galectin protein drug therapeutics for the treatment of cancer and liver disease.
Business Model: unknown
Revenue: 1M
Employees: 9
Industry: Biopharma
Axsome is a biotechnology firm that develops and commercializes novel therapies for the treatment of central nervous system disorders.
Business Model: unknown
Revenue: 25.7M
Employees: 150
Industry: Biopharma
Umoja is a Washington-based biotechnology company that develops and commercializes CAR T-cell therapies for the treatment of cancer.
Business Model: unknown
Revenue: 1M
Employees: 30
Industry: Biopharma
NGM Bio is a clinical stage biopharmaceutical company that develops biologic drugs for the treatment of cardio-metabolic and liver disease.
Business Model: unknown
Revenue: 58.1M
Employees: 220
Industry: Biopharma
Ocugen is a Pennsylvania-based biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of ocular disorders.
Business Model: unknown
Revenue: 42.6k
Employees: 60
Industry: Biopharma
ESSA is a Canada-based pharmaceutical company that develops and commercializes small molecule drugs for the treatment of prostate cancer.
Business Model: unknown
Revenue: 8.8M
Employees: 50
Industry: Biopharma
Xenon is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological disorders.
Business Model: unknown
Revenue: 13.2M
Employees: 153
Industry: Biopharma
PrognomiQ is a California-based biotechnology company that develops transformative test products for the early detection and treatment of cancer.
Business Model: unknown
Revenue: 2M
Employees: 30
Industry: Biopharma
Marinus is a Pennsylvania-based biopharmaceutical company that develops and commercializes therapies for the treatment of epilepsy and neuropsychiatric disorders.
Business Model: unknown
Revenue: 19.8M
Employees: 110
Industry: Biopharma
Imcheck is a France-based biotechnology company that develops and commercializes immunotherapeutic antibodies for the treatment of cancer, infectious and autoimmune diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 35
Industry: Biopharma
BioXcel Therapeutics is a Connecticut-based biopharmaceutical company that develops transformative medicines for the treatment of neurodegenerative disorders and cancer.
Business Model: unknown
Revenue: 137k
Employees: 90
Industry: Biopharma
Mereo BioPharma is an England-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 49.2M
Employees: 52
Industry: Biopharma
Vaxcyte is a California-based biotechnology company that researches and develops novel vaccines for the treatment of bacterial infectious diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 90
Industry: Biopharma
eGenesis is a Massachusetts-based biotechnology company that researches and develops human-compatible organs tissues, and cells for xenotransplantation operations.
Business Model: unknown
Revenue: 20M
Employees: 130
Industry: Biopharma
BlueRock Therapeutics is a Massachusetts-based biopharmaceutical company that develops induced pluripotent stem cell therapies for the treatment of intractable diseases.
Business Model: unknown
Revenue: 10.2M
Employees: 200
Industry: Biopharma
KSQ Therapeutics is a biotechnology company that develops genome-based therapeutics for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 2M
Employees: 50
Industry: Biopharma
Mirati is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 11.8M
Employees: 420
Industry: Biopharma
GenScript ProBio is a one-stop biopharmaceutical R&a;D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Biopharma
Stealth is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of mitochondrial dysfunctions.
Business Model: unknown
Revenue: 21.1M
Employees: 40
Industry: Biopharma
AstraZeneca is an England-based pharmaceutical firm that develops and commercializes prescription medicines to the treatment of a range of diseases such as oncology and renal.
Business Model: unknown
Revenue: 41.5B
Employees: 79.6k
Industry: Biopharma
MEI Pharma is an oncology company that focuses on the clinical development of novel therapies for cancer.
Business Model: unknown
Revenue: 40.7M
Employees: 100
Industry: Biopharma
Corvia Medical is a Massachusetts-based medical device company that develops and markets transcatheter devices for the treatment of heart failures.
Business Model: unknown
Revenue: 8M
Employees: 35
Industry: Biopharma
Alto is a California-based clinical-stage biotechnology company that develops precision psychiatry medicines for the treatment of post-traumatic stress disorder.
Business Model: unknown
Revenue: 2M
Employees: 50
Industry: Biopharma
Teva is a is an Israel-based pharmaceutical company that develops and commercializes generic drugs for the treatment of cancer and respiratory diseases across the globe.
Business Model: unknown
Revenue: 15.6B
Employees: 36k
Industry: Biopharma
Biosyntia is a Denmark-based biotechnology company that develops synthetic and metabolic biocatalysts for the production of chemical compounds.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Biopharma
SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
Business Model: unknown
Revenue: 35M
Employees: 190
Industry: Biopharma
Arbor Biotechnologies is a Massachusetts-based biotechnology company that develops and commercializes medicines for the treatment of genetic diseases.
Business Model: unknown
Revenue: 6M
Employees: 60
Industry: Biopharma
Locus Biosciences is a North Carolina-based biotechnology company that researches and develops novel precision therapeutics to treat inflammatory and infectious diseases.
Business Model: unknown
Revenue: 4.9M
Employees: 63
Industry: Biopharma
GTx is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model: unknown
Revenue: 2.4M
Employees: 11
Industry: Biopharma
Krystal Biotech is a pharmaceutical firm that researches and develops novel therapeutics for the treatment of skin diseases using gene therapy.
Business Model: unknown
Revenue: 1M
Employees: 120
Industry: Biopharma
Yisheng Biopharma is a biopharmaceutical company that develops and commercializes novel immunotherapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 3M
Employees: 500
Industry: Biopharma
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women&s;s cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Histogen is a California-based biotechnology company that develops and commercializes restorative therapeutics for the treatment of dermal rejuvenation and aesthetic diseases.
Business Model: unknown
Revenue: 3.8M
Employees: 20
Industry: Biopharma
Fusion Pharma develops and commercializes targeted alpha-particle radiotherapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 1.6M
Employees: 86
Industry: Biopharma
POINT is a pharmaceutical firm that researches, develops, and commercializes radioligand therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 72
Industry: Biopharma
Manus Bio is a biotechnology company that converts plant sugar into hydrogen molecules to produce nutraceutical, beauty and wellness products.
Business Model: unknown
Revenue: 5M
Employees: 70
Industry: Biopharma
Soligenix is a New Jersey-based late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and rare diseases.
Business Model: unknown
Revenue: 899k
Employees: 10
Industry: Biopharma
ACELYRIN is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of inflammatory diseases.
Business Model: unknown
Revenue: 3.6M
Employees: 50
Industry: Biopharma
Arcutis is a California-based biotechnology company that researches and develops novel therapies for the treatment of immune-mediated skin diseases.
Business Model: unknown
Revenue: 725k
Employees: 150
Industry: Biopharma
Oyster Point is a New Jersey-based biopharmaceutical company that researches and develops novel therapies for the treatment of ophthalmic diseases.
Business Model: unknown
Revenue: 19.6M
Employees: 180
Industry: Biopharma
Zentalis is a New York-based clinical-stage biopharmaceutical company that researches and develops small molecule therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 14k
Employees: 180
Industry: Biopharma
Tenaya is a California-based biotechnology company that develops and researches curative therapies for the treatment of cardiovascular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 120
Industry: Biopharma
Cullinan is a Massachusetts-based biopharmaceutical company that develops and commercializes immuno-oncology therapies for the treatment of cancer and autoimmune disorders.
Business Model: unknown
Revenue: 18.9M
Employees: 30
Industry: Biopharma
Angion is a biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of fibrotic diseases.
Business Model: unknown
Revenue: 28.2M
Employees: 70
Industry: Biopharma
Seres Therapeutics is a clinical-stage biotherapeutic company that researches and develops ecobiotic therapeutic products.
Business Model: unknown
Revenue: 13.4M
Employees: 330
Industry: Biopharma
Fluxa is a California-based digital transformation company that offers solutions such as contract process development and analytics for the life science sector.
Business Model: unknown
Revenue: 2.5M
Employees: 21
Industry: Biopharma
Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets. It provides a one-stop-shop with comprehensive capabilities from Cell line and Process Development through to scale up, cGMP manufacturing, and fills/finish of proteins and peptides. Offer services at every stage of the development life cycle from Pre-Clinical and Clinical Development to Commercial Supply. At Stelis BioSource™, we assure customers of CDMO/CMO services, our deep commitment to Quality, Service, and Compliance. Stelis Biopharma Pvt. Ltd. (Stelis) was started in 2013 by Strides Pharma Science Limited (Strides) to drive a global affordable biopharma business. Via on-going investment, Strides remains a majority owner of Stelis alongside GMS Holdings and Tenshi Life Sciences. It continues to operate as an independent and autonomous subsidiary company.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Adicet Bio is a California-based biotechnology company that develops and commercializes T cell therapies for the treatment of cancer.
Business Model: unknown
Revenue: 9.7M
Employees: 90
Industry: Biopharma
AskBio is a biotechnology firm that develops and commercializes AAV gene therapies for the treatment of muscular dystrophy and genetic disorders.
Business Model: unknown
Revenue: 46.5M
Employees: 325
Industry: Biopharma
Aduro Biotech develops clinical-stage biotechnology immunotherapy solutions for the treatment of cancer.
Business Model: unknown
Revenue: 827k
Employees: 105
Industry: Biopharma
Poseida is a California-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of cancer and genetic diseases.
Business Model: unknown
Revenue: 151.7M
Employees: 280
Industry: Biopharma
Nuvectis is a New Jersey based biopharmaceutical company that develops and delivers novel targeted therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 8
Industry: Biopharma
Dianthus is a Massachusetts-based biotechnology company that develops and commercializes monoclonal antibody therapies for the treatment of autoimmune diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 15
Industry: Biopharma
Satellite Bio is a Massachusetts-based biotechnology company that develops and commercializes implantable organs for treating patients with serious diseases.
Business Model: unknown
Revenue: 2.4M
Employees: 40
Industry: Biopharma
Be Biopharma is a Massachusetts-based biotechnology company that develops and commercializes cell therapies for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 5M
Employees: 60
Industry: Biopharma
Abzena is an England-based contract research organization that offers services such as antibody discovery and drug conjugate development for the biopharmaceutical sector.
Business Model: unknown
Revenue: 11M
Employees: 317
Industry: Biopharma
Apexigen is a biopharmaceutical company that develops and commercializes antibody-based immuno-oncology therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 20
Industry: Biopharma
Michael is well known for leading a merger of the cannabis cultivation company he built and operated as CEO and Chairman, called Solaris Farms, with The Sanctuary. In four years, Michael was able to build Solaris out from a bare lot of land into one of the largest and most well-respected private double cannabis verticals in Nevada today. Michael remains on the advisory board of Solaris and will help advise the company with future mergers and acquisitions. He continues to build much needed infrastructure in emerging states in the USA. Michael Sassano broke ground on what would become Solaris Farms in 2016 after traveling around the world touring different types of agricultural greenhouses and observing the various technologies used to produce high-quality yields in harsh climates. From the get-go, he envisioned building a major cultivation company in Nevada’s business-friendly environment which he’d either sell or expand to maximum government approved canopy. Solaris has a rotation of 7,000 plants and bi-monthly 1000 plant harvests which are sold at every major dispensary in Las Vegas and throughout Nevada. Michael built Solaris Farms into a Las Vegas icon but also gathered global recognition which he plans to continue expanding. The grow exists on a portion of the land which is state-approved for cultivation space of over 300,000 sq ft. When fully built out, Solaris will be one of the 20 largest cannabis grows in the United States, according to Greenhouse Grower (https://www.greenhousegrower.com/crops/cannabis/cannabis-top-20-north-americas-largest-commercial-grows/)
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
3T is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of solid tumors and immune-mediated diseases.
Business Model: unknown
Revenue: 2M
Employees: 26
Industry: Biopharma
Fennec is a North Carolina-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of pediatric cancer.
Business Model: unknown
Revenue: 170k
Employees: 10
Industry: Biopharma
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients. The company identifies rare bioactive compounds and, through rigorous research, develops those with the greatest potential for human health and wellbeing. Demetrix methods mimic nature’s chemistry, and we produce bioactives efficiently and affordably, maintaining a light environmental footprint. Demetrix is based in Berkeley, CA, with offices in Raleigh, NC.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Accession Therapeutics is an England-based biotechnology company that researches and develops novel immuno-therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 1M
Employees: 20
Industry: Biopharma
Kadmon is a New York-based biopharmaceutical company that discovers, develops and commercializes drugs for the treatment of cancer and immunology disorders.
Business Model: unknown
Revenue: 8.3M
Employees: 127
Industry: Biopharma
TRexBio is a California-based biotechnology company that researches and commercializes novel therapeutics for the treatment of cancer and inflammatory diseases.
Business Model: unknown
Revenue: 2.2M
Employees: 42
Industry: Biopharma
Lantern Pharma is a biotechnology company that develops and commercializes small molecule therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 1.5M
Employees: 20
Industry: Biopharma
64x Bio is a California-based synthetic biology company that develops and commercializes enhanced cell lines for biomanufacturing and therapeutics.
Business Model: unknown
Revenue: 5M
Employees: 10
Industry: Biopharma
Touchlight is an England-based contract development company that offers services including DNA manufacturing and regulatory support for the pharmaceutical sector.
Business Model: unknown
Revenue: 7.1M
Employees: 125
Industry: Biopharma
HiFiBiO is a Massachusetts-based biotherapeutics company that discovers, develops and commercializes antibody drugs for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 3.9M
Employees: 70
Industry: Biopharma
HUTCHMED is a China-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and immunological diseases.
Business Model: unknown
Revenue: 356.1M
Employees: 1.3k
Industry: Biopharma
Loxo Oncology develops and markets genomic medicines for the treatment of cancer.
Business Model: unknown
Revenue: 124M
Employees: 400
Industry: Biopharma
Arrakis Therapeutics develops and commercializes RNA-targeted small molecules for the treatment of neurology, oncology and genetic disorders.
Business Model: unknown
Revenue: 3.4M
Employees: 40
Industry: Biopharma
Dynavax is a biopharmaceutical company that discovers, develops and commercializes novel vaccines for the treatment of cancer.
Business Model: unknown
Revenue: 733.3M
Employees: 310
Industry: Biopharma
AeroSafe is a New York-based cold-chain technology company that provides solutions such as packaging, logistics and supply chain management for the biopharma industry.
Business Model: unknown
Revenue: 35M
Employees: 275
Industry: Biopharma
ALX Oncology is a California-based biotechnology company that researches and develops immuno-oncology therapies for the treatment of cancer.
Business Model: unknown
Revenue: 1.2M
Employees: 50
Industry: Biopharma
Ultivue is a Massachusetts-based biotechnology company that develops tissue phenotyping biomarker assay products for the healthcare industry.
Business Model: unknown
Revenue: 2.3M
Employees: 100
Industry: Biopharma
METiS is a Massachusetts-based discovery technology and therapeutics company that develops optimal therapies for patients with cancer and infectious diseases.
Business Model: unknown
Revenue: 3.2M
Employees: 70
Industry: Biopharma
Calibre Scientific is a California-based company that manufactures products such as assay kits, reagents and consumables for life sciences and diagnostics markets.
Business Model: unknown
Revenue: 15M
Employees: 300
Industry: Biopharma
Ventyx is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune and inflammatory diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
Zerigo is a California-based medical device company that develops and commercializes NB-UVB Phototherapy systems for the treatment of chronic skin conditions.
Business Model: unknown
Revenue: 1M
Employees: 15
Industry: Biopharma
Urovant is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of urologic conditions.
Business Model: unknown
Revenue: 104.6M
Employees: 70
Industry: Biopharma
Portola is a biotechnology company that develops and commercializes novel therapeutics for the treatment of thrombotic and hematologic disorders.
Business Model: unknown
Revenue: 120.9M
Employees: 408
Industry: Biopharma
Immune-Onc is a California-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and solid tumors.
Business Model: unknown
Revenue: 5M
Employees: 15
Industry: Biopharma
Elevian is a Massachusetts-based biotechnology company that develops and commercializes regenerative medicines for the treatment of age-related diseases.
Business Model: unknown
Revenue: 4.2M
Employees: 24
Industry: Biopharma
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics. The company was founded in 2021 and is headquartered in Belmont, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Othram has developed a cloud-based platform that focuses on reconstructing genome sequences from degraded and low-input DNA sources for forensic purposes.
Business Model: unknown
Revenue: 5M
Employees: 25
Industry: Biopharma
Selecta Biosciences is a biotechnology company that develops and commercializes immunotherapies for the treatment of autoimmune diseases.
Business Model: unknown
Revenue: 123.9M
Employees: 60
Industry: Biopharma
Artios is an England-based biotechnology company that researches and develops DNA damage response therapies for the treatment of cancer.
Business Model: unknown
Revenue: 3M
Employees: 90
Industry: Biopharma
Innovent Biologics engages in research and development of monoclonal antibody drugs for cancer and autoimmune diseases.
Business Model: unknown
Revenue: 588.9M
Employees: 4.5k
Industry: Biopharma
Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Bluestar Genomics delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Harmony Biosciences is a Pennsylvania-based pharmaceutical company that develops and commercializes novel therapeutics for the treatment of neurological diseases.
Business Model: unknown
Revenue: 400.8M
Employees: 180
Industry: Biopharma
Enlaza Therapeutics is a biotechnology research company. It was founded in 2020 and is headquartered in La Jolla, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Hyasynth Bio is a biotechnology company that develops and commercializes cannabinoids for the healthcare industry.
Business Model: unknown
Revenue: 5M
Employees: 30
Industry: Biopharma
Corvus Pharmaceuticals is focused on the development of novel agents targeting the immune system to treat patients with cancer.
Business Model: unknown
Revenue: 580k
Employees: 30
Industry: Biopharma
Cyteir is a Massachusetts-based biotechnology company that develops and commercializes therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
AccutarBio employs artificial intelligence to revolutionize drug discovery. AccutarBio&s;s philosophy is to derive a data-driven principle that has the power of explaining physical and chemical nature of biological systems, which we harness to accelerate drug discoveries.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Liquidia is a North Carolina-based biopharmaceutical company that researches and develops novel therapies for the treatment of pulmonary arterial hypertension.
Business Model: unknown
Revenue: 13.8M
Employees: 50
Industry: Biopharma
Adaptimmune is a biotechnology company that researches and develops T-cell receptors for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 17.5M
Employees: 494
Industry: Biopharma
HDT Bio is a biotechnology company that develops immunotherapies for the treatment of oncology and infectious disease
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Genomics is a healthcare company that researches and develops therapies for the treatment of genetic diseaeses.
Business Model: unknown
Revenue: 2M
Employees: 71
Industry: Biopharma
Enterome develops and commercializes therapies for the treatment of microbiome, cancer and metabolic diseases.
Business Model: unknown
Revenue: 5M
Employees: 60
Industry: Biopharma
Sirnaomics is a Maryland-based biopharmaceutical company that develops and commercializes RNAi therapeutics for the treatment of cancer, fibrosis and metabolic diseases.
Business Model: unknown
Revenue: 7.5M
Employees: 56
Industry: Biopharma
Icosagen Group is a contract research provider and technology developer for biopharmaceutical and biotechnology industries and academia that offers high-end biotechnology services and products. The company’s services include protein production, antibody production, and VLP production. Its products include antibodies, proteins, ELISA kits, transfection reagent, and DNA/RNA isolation. It also offers quality control services such as food microbiology testing services and FITkit for latex allergen testing. Icosagen Group participates in several international and national research programs and projects, including INTENSO, MAARS, and EURIPRED. Its QMCF Technology is a stable episomal expression system that uses specific mammalian cells and appropriate vectors for production of secretable and intracellular recombinant proteins, antibodies, virus-like particles; and for expression of intracellular proteins at physiologically relevant level for development of cell-based assays for screening purposes. The Group is comprised of three entities: parent company Icosagen AS and two subsidiaries: Icosagen Cell Factory Ltd and IcoPark Ltd. Icosagen Group is based in Tartumaa, Estonia.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company&s;s drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
VoxCell is creating an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research by creating vascularized cancer tissue models.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Innate Pharma is a France-based biotechnology company that develops and commercializes therapeutic antibodies for the treatment of cancer and inflammatory diseases.
Business Model: unknown
Revenue: 28M
Employees: 212
Industry: Biopharma
Amarin is an Ireland-based biopharmaceutical company that develops and commercializes therapeutic products for heart diseases.
Business Model: unknown
Revenue: 423.4M
Employees: 560
Industry: Biopharma
Ambrx is a California-based biopharmaceutical company that researches and develops antibody-drug and immuno-oncology conjugates for the treatment of cancer.
Business Model: unknown
Revenue: 7.5M
Employees: 80
Industry: Biopharma
Pharnext is a France-based clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 90.6k
Employees: 109
Industry: Biopharma
Arctoris is a provider of automated cell-based and biochemical research services for businesses.
Business Model: unknown
Revenue: 1.2M
Employees: 19
Industry: Biopharma
Allakos is a biotechnology company that researches, develops and commercializes antibody-based therapeutics for allergies and inflammatory diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 190
Industry: Biopharma
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies.
Business Model: unknown
Revenue: 7.5M
Employees: 92
Industry: Biopharma
ProPharma is a Kansas-based life sciences consulting firm that offers services such as regulatory compliance and medical information for the healthcare sector.
Business Model: unknown
Revenue: 143M
Employees: 2.5k
Industry: Biopharma
Axial Therapeutics is a clinical stage biopharmaceutical company harnessing the gut-brain axis to develop novel Central Nervous System (CNS) Therapeutics to improve the quality of life for people with CNS diseases and disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Omniome is a California-based DNA sequencing platform that provides solutions including genome analysis and testing for medical research centers.
Business Model: unknown
Revenue: 45M
Employees: 200
Industry: Biopharma
Gameto is a new breed of biotechnology firm dedicated to better understanding and treating infertility and menopause. The company aims to leverage the allogeneic human cellular derivatives of their platform to therapeutic applications for assisted fertility and menopause. Gameto was founded in 2020 and is based in New York.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
HBM is a biopharmaceutical company that discovers and develops immuno-oncology therapeutics for the treatment of cancer and inflammatory diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
“To Translate Novel Modality into Reality”. Duality Biologics was founded in January 2020 by Dr. John Zhu, a well-respected investor in the healthcare industry. Duality Bio is committed to developing novel modality drugs to fulfill the unmet medical needs for patients worldwide. Focusing on the oncology and autoimmune diseases, the company has built a novel internal pipeline including nearly 10 Best-in-Class and First-in-Class bispecific antibody and Antibody-Drug Conjugate (ADC) drugs, of which several drug candidates are in the IND stage. The company has successfully built the next-generation ADC platform with global intellectual property rights. The value of this platform has been validated by a number of drug candidates under development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
TreeFrog is a France-based biotechnology company that develops and commercializes iPS-derived cell therapies for the treatment of Parkinson’s disease.
Business Model: unknown
Revenue: 2.5M
Employees: 50
Industry: Biopharma
Evonetix is an England-based synthetic biology company that develops and commercializes DNA synthesis for healthcare, pharmaceuticals and data storage markets.
Business Model: unknown
Revenue: 6M
Employees: 80
Industry: Biopharma
Spectrum is a Nevada-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model: unknown
Revenue: 10.7M
Employees: 160
Industry: Biopharma
Blade Therapeutics is a biopharmaceutical company that researches, discovers and commercializes drugs for the treatment of fibrotic diseases.
Business Model: unknown
Revenue: 5.5M
Employees: 25
Industry: Biopharma
Rheos is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 50
Industry: Biopharma
ABclonal is a China-based biotechnology company that researches and develops antibodies and molecular enzyme products for industries such as life science and pharmaceuticals.
Business Model: unknown
Revenue: 7.1M
Employees: 100
Industry: Biopharma
Cytomos is a Scotland-based SaaS platform that offers predictive analytics solutions for the biopharmaceutical industry.
Business Model: unknown
Revenue: 5.2M
Employees: 44
Industry: Biopharma
Autolus is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 4.4M
Employees: 327
Industry: Biopharma
Compass Therapeutics is a Massachusetts-based biotechnology company that researches and develops antibody therapeutics for the treatment of cancer and tumor.
Business Model: unknown
Revenue: 8.5M
Employees: 20
Industry: Biopharma
ArkBio is a China-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of pediatric and respiratory diseases.
Business Model: unknown
Revenue: 11.2M
Employees: 55
Industry: Biopharma
LianBio is a biotechnology firm that researches and develops novel therapies for the treatment of oncology and cardiovascular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 107
Industry: Biopharma
Tocagen researches, discovers, develops and commercializes gene therapies for the treatment of cancer.
Business Model: unknown
Revenue: 36k
Employees: 9
Industry: Biopharma
Infinity is an drug discovery and development company.
Business Model: unknown
Revenue: 2.5M
Employees: 30
Industry: Biopharma
Foghorn Therapeutics discovers and develops novel drugs to treat cancer.
Business Model: unknown
Revenue: 5M
Employees: 120
Industry: Biopharma
Akari is an England-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of orphan autoimmune and inflammatory diseases.
Business Model: unknown
Revenue: 1M
Employees: 9
Industry: Biopharma
Theravance Biopharma is a biopharmaceutical company that develops organ-selective medicines for the treatment of respiratory diseases.
Business Model: unknown
Revenue: 51.6M
Employees: 160
Industry: Biopharma
Rallybio is a Connecticut based biopharmaceutical company that researches and develops novel therapeutics for the treatment of severe and rare disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
Tarsus is a biopharmaceutical company that develops therapies for demodex blepharitis and eye care.
Business Model: unknown
Revenue: 16.2M
Employees: 50
Industry: Biopharma
Principia is a biopharmaceutical company that develops small molecule drugs for the treatment of immune-mediated diseases.
Business Model: unknown
Revenue: 103.7M
Employees: 100
Industry: Biopharma
UroGen is a New Jersey-based biotech company that develops and commercializes novel therapies for the treatment of cancer and urologic diseases.
Business Model: unknown
Revenue: 62.4M
Employees: 200
Industry: Biopharma
resTORbio engages in the development and commercialization of novel therapeutics for the treatment of aging-related diseases.
Business Model: unknown
Revenue: 3M
Employees: 12
Industry: Biopharma
Sagimet is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and liver diseases.
Business Model: unknown
Revenue: 4M
Employees: 26
Industry: Biopharma
Reata focuses on developing novel therapeutics that target molecular pathways involved in the regulation of cellular metabolism and inflammation.
Business Model: unknown
Revenue: 3.1M
Employees: 350
Industry: Biopharma
Trillium is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 148k
Employees: 2k
Industry: Biopharma
Slayback researches, develops and commercializes generic and specialty pharmaceutical products for the healthcare industry.
Business Model: unknown
Revenue: 7M
Employees: 85
Industry: Biopharma
Lumen is a biopharmaceutical company that discovers, develops and manufactures biologic drugs and vaccines for prevalent diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Elevation Oncology is a New York-based biopharmaceutical company that researches and develops precision therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
ArcherDX is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications.
Business Model: unknown
Revenue: 50.5M
Employees: 260
Industry: Biopharma
Rondo is a California-based biopharmaceutical company that develops and commercializes therapies for the treatment of cancer.
Business Model: unknown
Revenue: 3.2M
Employees: 28
Industry: Biopharma
EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Ansun BioPharma is a drug discovery and development company that focuses on developing novel therapies for respiratory diseases.
Business Model: unknown
Revenue: 8M
Employees: 31
Industry: Biopharma
Denovo Biopharma is a biotechnology company that provides biomarker solutions to personalize drug development.
Business Model: unknown
Revenue: 8.5M
Employees: 42
Industry: Biopharma
Castle Creek is a Pennsylvania-based biotechnology company that develops and commercializes gene therapies for the treatment of skin, connective tissue and metabolic diseases.
Business Model: unknown
Revenue: 1M
Employees: 16
Industry: Biopharma
Kiniksa is a biopharmaceutical company focused on discovering, developing and commercializing therapeutic medicines for autoimmune diseases.
Business Model: unknown
Revenue: 177M
Employees: 220
Industry: Biopharma
Invetx is a Massachusetts-based biopharmaceutical company that develops and commercializes protein-based therapeutics for animal health conditions.
Business Model: unknown
Revenue: 3.5M
Employees: 28
Industry: Biopharma
Shattuck is a biotechnology company that develops and commercializes medicines for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 30.3M
Employees: 80
Industry: Biopharma
Bicara is a Massachusetts-based biotechnology company that provides immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Aurion Biotech is a Washington-based biotechnology company that researches and develops cell therapeutics for the treatment of corneal endothelial disease.
Business Model: unknown
Revenue: 10M
Employees: 50
Industry: Biopharma
This is a biotechnology company founded by professor Lee Sung-wook&s;s lab They are working on the development of gene therapy products for liver cancer through the development of gene therapy products. It was selected by the TIPS program and was recognized for excellence in technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Adamis is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory and inflammatory diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 20
Industry: Biopharma
Kojin is a Massachusetts-based biotechnology company that discovers and develops cell state biological therapeutics for the treatment of cancer, ischemia and fibrosis.
Business Model: unknown
Revenue: 1.9M
Employees: 15
Industry: Biopharma
Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson’s disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10
Industry: Biopharma
3D Medicines is a provider of personalized diagnostics and treatment for cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Biopharma
Astria is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of allergic and immunological diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
Genelux is a California-based clinical-stage immuno-oncology company company that develops and commercializes immunotherapeutics for the treatment of cancerin individuals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Edgewise Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
Zealand is a Denmark-based biotechnology company that develops and markets peptide-based therapeutics to treat metabolic and gastrointestinal diseases.
Business Model: unknown
Revenue: 29.8M
Employees: 237
Industry: Biopharma
Ascentage Pharma engages in the research and development of structure based molecule drugs for cancer therapeutics.
Business Model: unknown
Revenue: 1.9M
Employees: 433
Industry: Biopharma
Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines.
Business Model: unknown
Revenue: 659k
Employees: 40
Industry: Biopharma
Inscopix is a California-based brain mapping platform that identifies treatments and therapeutics for brain diseases.
Business Model: unknown
Revenue: 15M
Employees: 90
Industry: Biopharma
Rockwell Medical is a Michigan-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of iron deficiency and anemia.
Business Model: unknown
Revenue: 68.8M
Employees: 300
Industry: Biopharma
Arbutus is a biopharmaceutical firm that develops therapies for the treatment of hepatitis B virus infection.
Business Model: unknown
Revenue: 36M
Employees: 90
Industry: Biopharma
Sanegene Bio is currently operating in stealth mode.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
NextCure is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer.
Business Model: unknown
Revenue: 48.3M
Employees: 90
Industry: Biopharma
Intra-Cellular Therapies is a biopharmaceutical company founded on research that uncovered how therapies affect the inner-working of cells in the human body.
Business Model: unknown
Revenue: 188.1M
Employees: 510
Industry: Biopharma
Felix Biotechnology is a California-based biotechnology company that researches and develops novel biotherapeutics for drug-resistant bacterial infections.
Business Model: unknown
Revenue: 8.9M
Employees: 12
Industry: Biopharma
Immunomedics is a biopharmaceutical company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer.
Business Model: unknown
Revenue: 21.5M
Employees: 366
Industry: Biopharma
PMV Pharma is a biopharmaceutical company that develops and commercializes small-molecule drugs for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 50
Industry: Biopharma
Raptor develops and commercializes therapeutics for the treatment of cystinosis, Huntington and Cystic Fibrosis diseases.
Business Model: unknown
Revenue: 110M
Employees: 158
Industry: Biopharma
Antios is a Georgia-based biopharmaceutical company that develops and commercializes therapies for the treatment of viral diseases.
Business Model: unknown
Revenue: 3M
Employees: 45
Industry: Biopharma
NeuSpera is a California-based medical device company that manufactures minimally-invasive implants with external wearable transmitters for patients with chronic illnesses.
Business Model: unknown
Revenue: 5M
Employees: 50
Industry: Biopharma
Paratek is a biopharmaceutical company that researches, develops, and commercializes antibiotic therapies for the treatment of infectious diseases.
Business Model: unknown
Revenue: 116.5M
Employees: 210
Industry: Biopharma
Enalare is a New Jersey-based biopharmaceutical company that develops novel therapies for the treatment of acute respiratory conditions.
Business Model: unknown
Revenue: 450k
Employees: 18
Industry: Biopharma
InVivo is a France-based agriculture company that cultivates and distributes food products across the globe.
Business Model: unknown
Revenue: 12.8B
Employees: 98
Industry: Biopharma
Gemini is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of macular degeneration diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
SciNeuro is a biopharmaceutical firm that develops and commercializes therapeutics for the treatment of CNS diseases.
Business Model: unknown
Revenue: 3M
Employees: 8
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Navitor is a biopharmaceutical company that develops and commercializes medicines for the treatment of chronic age-related diseases.
Business Model: unknown
Revenue: 3M
Employees: 30
Industry: Biopharma
Concerto is a Massachusetts-based biotechnology company that discovers microbial ensembles for the treatment of eczema.
Business Model: unknown
Revenue: 1M
Employees: 20
Industry: Biopharma
TESARO is a biopharmaceutical company that identifies, acquires, develops and commercializes cancer therapeutics.
Business Model: unknown
Revenue: 213M
Employees: 715
Industry: Biopharma
Antengene is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 4.5M
Employees: 51 - 500
Industry: Biopharma
Attralus is a California-based biopharmaceutical company that develops novel pan-amyloid removal therapeutics for the treatment of systemic amyloid diseases.
Business Model: unknown
Revenue: 2M
Employees: 15
Industry: Biopharma
Imara develops novel therapeutics for the treatment of sickle cell disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
CN Bio is an England-based biotechnology company that designs and manufactures single and multi-organ microphysiological systems for healthcare organizations.
Business Model: unknown
Revenue: 4M
Employees: 75
Industry: Biopharma
Tierra is a California-based synthetic biology company that develops bioengineered products for the healthcare industry.
Business Model: unknown
Revenue: 3M
Employees: 28
Industry: Biopharma
Huida Gene is a China-based biotechnology company that researches, develops and commercializes medicines for the treatment of genetic disorders.
Business Model: unknown
Revenue: 5M
Employees: 200
Industry: Biopharma
Aprecia is an Ohio-based 3DP drug delivery company that provides services such as NCE commercialization, and alliance management for the pharmaceutical sector.
Business Model: unknown
Revenue: 7M
Employees: 67
Industry: Biopharma
FibroGen discovers, develops, and commercializes novel therapeutics for the treatment of pulmonary fibrosis and pancreatic cancer.
Business Model: unknown
Revenue: 122.9M
Employees: 570
Industry: Biopharma
Indapta is a Texas-based biotechnology company that develops and commercializes G-NK cell therapies for the treatment of cancer.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Biopharma
Interius is a Pennsylvania-based biotechnology firm that researches and develops T-cell gene therapies for the treatment of malignant hematological tumors.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Biopharma
Pattern Computer is a pattern discovery company that discover invisible patterns in their existing operational data.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Artax is a Massachusetts-based biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of autoimmune and inflammatory diseases.
Business Model: unknown
Revenue: 4.4M
Employees: 27
Industry: Biopharma
Huisheng Bio is a diabetes and complication treatment solution provider. The company was founded in 2019 and is headquartered in Jilin, China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
OriginCell is a biomedical equipment enterprise that develops tumor immuno-therapy solutions. It develops tumor therapies and cellular drugs through the use of the 10-phage display library, humanized antibody technology platform, and antibody discovery platform that enable their medical facilities to apply in cancer treatments. OriginCell was founded in 2014 and is headquartered in Shanghai, China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
GH Research is an Ireland-based biopharmaceutical company that develops novel therapies for the treatment of psychiatric and neurological disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 8
Industry: Biopharma
AZTherapies is a clinical-stage biopharmaceutical company that develops novel small molecules therapeutics to treat neurodegenerative diseases.
Business Model: unknown
Revenue: 5M
Employees: 29
Industry: Biopharma
Rainier is a pharmaceutical company that develops protein-based therapeutics for genetic disorders.
Business Model: unknown
Revenue: 11M
Employees: 25
Industry: Biopharma
Otonomy is a California-based biopharmaceutical company that researches and develops novel therapeutics for patients with hearing disorders.
Business Model: unknown
Revenue: 125k
Employees: 50
Industry: Biopharma
CymaBay is a biopharmaceutical company that focuses on developing therapies for liver and chronic diseases.
Business Model: unknown
Revenue: 19.2M
Employees: 60
Industry: Biopharma
VIVUS develops and commercializes drug therapies to treat patients with serious medical conditions.
Business Model: unknown
Revenue: 75M
Employees: 120
Industry: Biopharma
Founded in 2020, Cargene Biopharma is a preclinical-stage biopharmaceutical company developing innovative oligonucleotide therapeutics for liver fibrosis and ophthalmic disorders, with operations in Singapore, USA and China. Cargene uses proprietary platforms backed by novel biology and chemistry insights, Cargene aims to improve quality of life for millions of patients worldwide through creating highly specific, stable and potent nucleic acid-based medicines for the treatment of a broad range of diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. This technology will allow clinicians to quickly determine which patients are responding to cancer therapies, allowing non-responders to be moved onto another line of therapy more quickly. The company was founded in 2015 and is based in Ulm, Germany.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Aptinyx researches, discovers, develops and commercializes novel therapies for the treatment of brain and nervous system disorders.
Business Model: unknown
Revenue: 1M
Employees: 40
Industry: Biopharma
Akeso is a biopharmaceutical firm that develops and commercializes anti-body drugs for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 35.4M
Employees: 1.9k
Industry: Biopharma
Eolo is a biotechnology company that develops and commercializes anti-obesity drugs for the treatment of diabetes and chronic inflammation.
Business Model: unknown
Revenue: 2M
Employees: 10
Industry: Biopharma
Eidos Therapeutics is a biopharmaceutical company that develops a novel oral therapy to treat transthyretin amyloidosis.
Business Model: unknown
Revenue: 26.7M
Employees: 24
Industry: Biopharma
Ganymede is a low-code bio-aware PaaS for biotech software engineering that enables users to connect apps, ingest data, and construct pipelines. Ganymede allows software engineers to create integrations, link software and hardware, and move data around using easy versioning. Ganymede is headquartered in Palo Alto, California and was founded in 2022.
Business Model: unknown
Revenue: 1M
Employees: 1 - 10
Industry: Biopharma
ValenzaBio is a Maryland-based biopharmaceutical company that develops monoclonal antibody therapeutics for the treatment of autoimmune and inflammatory diseases.
Business Model: unknown
Revenue: 1.9M
Employees: 15
Industry: Biopharma
Cimeio is a Switzerland-based biotechnology company that develops and commercializes cell therapies for the treatment of genetic and autoimmune disorders.
Business Model: unknown
Revenue: 1M
Employees: 20
Industry: Biopharma
Amphista is a Scotland-based biotechnology company that develops novel therapies for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
Entera Bio develops novel oral drugs therapeutics for the treatment of hypoparathyroidism.
Business Model: unknown
Revenue: 353k
Employees: 21
Industry: Biopharma
Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company&s;s Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Prelude Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 110
Industry: Biopharma
Ethris is a Germany-based biotechnology company that develops and commercializes mRNA-based therapeutics for the treatment of respiratory viral infections.
Business Model: unknown
Revenue: 9.5M
Employees: 40
Industry: Biopharma
Akston is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetes and cancer.
Business Model: unknown
Revenue: 2.3M
Employees: 30
Industry: Biopharma
Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.
Business Model: unknown
Revenue: 257k
Employees: 20
Industry: Biopharma
HaiHe Biopharma is a biopharmaceutical company that discovers, develops and commercializes anti-tumor drugs for the treatment of cancer.
Business Model: unknown
Revenue: 1
Employees: 189
Industry: Biopharma
Ovid Therapeutics is a biotechnology firm that focuses on developing therapies to treat neurological disorders.
Business Model: unknown
Revenue: 216.8M
Employees: 50
Industry: Biopharma
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Dermira develops and commercializes therapeutics for the treatment of dermatological diseases.
Business Model: unknown
Revenue: 82.9M
Employees: 333
Industry: Biopharma
Nanome is a VR-based software company that provides molecular structure analysis and drug discovery solutions for medical research centers.
Business Model: unknown
Revenue: 1M
Employees: 20
Industry: Biopharma
Verastem is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 1.6M
Employees: 50
Industry: Biopharma
Numab is a Switzerland-based biopharmaceutical company that develops and commercializes immuno-oncology therapies for the treatment of cancer.
Business Model: unknown
Revenue: 52.2M
Employees: 50
Industry: Biopharma
Landos Biopharma is a Virginia-based biopharmaceutical company that discovers and develops oral therapeutics for the treatment of autoimmune diseases.
Business Model: unknown
Revenue: 18M
Employees: 50
Industry: Biopharma
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Business Model: unknown
Revenue: 240.9M
Employees: 170
Industry: Biopharma
Enterin is engaged in the development of novel compounds for the treatment of Parkinson's disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Aileron develops and commercializes stapled peptide therapeutics for the treatment of cancer, inflammatory and infectious diseases.
Business Model: unknown
Revenue: 4M
Employees: 9
Industry: Biopharma
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Business Model: unknown
Revenue: 25.9M
Employees: 170
Industry: Biopharma
Swiftscale is a California-based cell-free protein synthesis platform that catalyzes and optimizes the clinical development and production of protein therapeutics.
Business Model: unknown
Revenue: 2.5M
Employees: 20
Industry: Biopharma
Curi Bio is a Washington-based preclinical platform that offers drug discovery solutions for the pharmaceutical sector.
Business Model: unknown
Revenue: 3.2M
Employees: 26
Industry: Biopharma
Kuros is engaged in the development of orthobiologics and sealant products for tissue repair and regeneration.
Business Model: unknown
Revenue: 726.2k
Employees: 28
Industry: Biopharma
Viracta is a California-based biotechnology company that researches and develops novel therapeutics to treat cancer and virus-affected diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
HilleVax is a Massachusetts-based biopharmaceutical company that develops and commercializes novel vaccines for the treatment of acute gastroenteritis disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 20
Industry: Biopharma
DMed is a contract research organization that offers clinical consultation and drug development services for the healthcare industry.
Business Model: unknown
Revenue: 5M
Employees: 600
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Wren is an England-based biopharmaceutical company that develops protein-containing drug discovery platforms for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 790.6k
Employees: 50
Industry: Biopharma
Advaccine is a biotechnology firm that develops and commercializes vaccines for the prevention and therapeutics of common diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
BioQ is a pharmaceutical company that develops and commercializes infusible therapeutics for the treatment of post-surgical pain management.
Business Model: unknown
Revenue: 4M
Employees: 40
Industry: Biopharma
ECO is a biopharmaceutical company that researches, develops and commercializes oncology products for the treatment of cancer.
Business Model: unknown
Revenue: 1.5M
Employees: 10
Industry: Biopharma
Transcenta is a pharmaceutical company that researches, develops and commercializes antibody therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Skye is a California-based biopharmaceutical company that develops and commercializes cannabinoid-based therapeutics for the treatment of glaucoma and a range of diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 9
Industry: Biopharma
METiS is a China-based biotechnology company that develops and commercializes AI-powered drug discovery and preparation development automation for the pharmaceutical industry.
Business Model: unknown
Revenue: 2M
Employees: 20
Industry: Biopharma
Artizan Biosciences is a Connecticut-based biotechnology firm that develops and commercializes microbiome precision medicines for autoimmune, and neurodegenerative diseases.
Business Model: unknown
Revenue: 2.1M
Employees: 12
Industry: Biopharma
Kiromic is a Texas-based biotherapeutics company that discovers and develops cell and gene therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 60
Industry: Biopharma
Trevena is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of CNS.
Business Model: unknown
Revenue: 378k
Employees: 40
Industry: Biopharma
Nodexus is a Venture- and SBIR-backed biotech startup commercializing the NX One platform to address widespread unmet needs for accessible live single cell isolation in industrial/biopharma, clinical research, and academic sectors. The NX One platform consists of a low-infrastructure, low-cost hardware system and single-use disposable microfluidic cartridges tailored toward live single-cell workflows involving gene editing (e.g. CRISPR engineering), cell line/antibody development, and tumor heterogeneity studies.
Business Model: unknown
Revenue: 381.6k
Employees: 5
Industry: Biopharma
INCOG BioPharma Services include injectable drug product formulation development, analytical method development, process scale up, and formulation &a; filling of vials, syringes and cartridges. In addition, they offer customized packaging services to include labeling, device assembly, final packaging and integrated storage solutions at various temperature conditions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Cardior is a Germany-based biopharmaceutical company that develops and commercializes RNA-based therapeutics for the treatment of heart diseases.
Business Model: unknown
Revenue: 3.1M
Employees: 40
Industry: Biopharma
SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders.
Business Model: unknown
Revenue: 5.8M
Employees: 32
Industry: Biopharma
Systemic Bio is a company that creates bioprinted organs-on-chips for drug discovery and development. Its proprietary platform is built with production-level 3D Systems technology, which has at least 10x greater build volume and up to 10x higher resolution than commercially available technologies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
AEterna Zentaris Inc. is a drug development company specialized in oncology and endocrine therapy. The Company&s;s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products. The priorities in oncology are its Phase III program with perifosine in multiple myeloma and its Phase II program in multiple cancers, including metastatic colon cancer, as well as Phase II program with AEZS-108 in advanced endometrial and advanced ovarian cancer combined with potential developments in other cancer indications. In endocrinology, the Company&s;s program is the reactivation of a Phase III trial with AEZS-130 (SolorelTM) as a growth hormone (GH) stimulation test for the diagnosis of GH deficiency in adults (AGHD).
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Ablynx is a biopharmaceutical company that engages in the discovery and development of Nanobodies for the small-molecule drug applications.
Business Model: unknown
Revenue: 108M
Employees: 450
Industry: Biopharma
Silk Therapeutics is a specialty biomaterials company that manufactures and sells skin care products based on silk materials.
Business Model: unknown
Revenue: 0 - 100000
Employees: 36
Industry: Biopharma
Catamaran Bio is a biotechnology company that researches and develops allogeneic CAR-NK cell therapies for the treatment of cancer.
Business Model: unknown
Revenue: 5M
Employees: 30
Industry: Biopharma
Invasight is a Switzerland-based biotechnology company that researches and commercializes targeted therapies for the treatment of cancer and infectious diseases.
Business Model: unknown
Revenue: 300k
Employees: 5
Industry: Biopharma
Cellestia is a Switzerland-based biotechnology company that researches and develops therapeutics to control and modulate pathogenic gene expression in cancer patients.
Business Model: unknown
Revenue: 2.1M
Employees: 20
Industry: Biopharma
Turbine is a Hungary-based AI platform that provides solutions including cell behavior simulation and cancer treatment identification for patients.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Biopharma
Sorrento Therapeutics focuses on the research and development of therapeutic products for the treatment of cancer, inflammation and autoimmune diseases.
Business Model: unknown
Revenue: 60.3M
Employees: 800
Industry: Biopharma
JOINN Biologics is a California-based CDMO that provides services such as developability assessment and biomass production for the pharmaceutical industry.
Business Model: unknown
Revenue: 5.5M
Employees: 70
Industry: Biopharma
Swixx Biopharma is a Switzerland-based holding company that owns, operates and represents biopharmaceutical and medical device manufacturers across the CEE region.
Business Model: unknown
Revenue: 305.2M
Employees: 600
Industry: Biopharma
Equillium is a California-based biotechnology firm that develops and commercializes immune-modifying therapeutics for the treatment of autoimmune and inflammatory disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
Juvena is a California-based biotechnology company that researches and develops therapeutics for the treatment of chronic and age-related diseases.
Business Model: unknown
Revenue: 2M
Employees: 30
Industry: Biopharma
Erytech Pharma develops therapies for rare forms of cancer and orphan diseases.
Business Model: unknown
Revenue: 5.1M
Employees: 206
Industry: Biopharma
Intensity Therapeutics is a pharmaceutical company that develops drugs and chemotherapy treatments for cancer patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 2
Industry: Biopharma
Onconova is a Pennsylvania-based biopharmaceutical company that develops and commercializes novel products for the treatment of cancer.
Business Model: unknown
Revenue: 226k
Employees: 10
Industry: Biopharma
Lineage is a California-based biotechnology company that develops and commercializes novel cell therapies for the treatment of degenerative diseases.
Business Model: unknown
Revenue: 14M
Employees: 60
Industry: Biopharma
Adendra is an England-based biotechnology company that develops and commercializes cell-based novel therapeutics for the treatment of solid tumors and autoimmune diseases.
Business Model: unknown
Revenue: 100k
Employees: 5
Industry: Biopharma
Inventiva is a France-based biopharmaceutical company that develops and commercializes oral small molecule therapies for the treatment of lysosomal storage disorders.
Business Model: unknown
Revenue: 9.6M
Employees: 88
Industry: Biopharma
Cue Biopharma focuses on developing a biologic treatment for wide range of diseases including cancers and autoimmune diseases.
Business Model: unknown
Revenue: 9.3M
Employees: 60
Industry: Biopharma
Nabla Bio is a Massachusetts-based AI platform that offers antibody design solutions for the healthcare industry.
Business Model: unknown
Revenue: 1M
Employees: 7
Industry: Biopharma
Vivet Therapeutics is a biotech company that develops and commercializes gene therapies for the treatment of liver disorders and orphan diseases.
Business Model: unknown
Revenue: 2M
Employees: 20
Industry: Biopharma
Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company&s;s core business includes the development, manufacture, and sale of plasma-derived products and other biopharmaceutical products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Biopharma
Taibang is a China-based biopharmaceutical company that develops and manufactures human plasma-based products for the treatment of hepatitis B, rabies, and tetanus diseases.
Business Model: unknown
Revenue: 536.5M
Employees: 2.3k
Industry: Biopharma
Kamada is an Israel-based biopharmaceutical company that develops and commercializes protein-based therapeutics for the treatment of AATD and infectious diseases.
Business Model: unknown
Revenue: 103.7M
Employees: 408
Industry: Biopharma
Keystone Dental is a Massachusetts-based manufacturer and distributor of dental implants and prosthetics for the healthcare industry.
Business Model: unknown
Revenue: 40M
Employees: 200
Industry: Biopharma
Axol is an England-based biotechnology company that develops human iPSC-derived cells, critical reagents and cell culture media for the life science industry.
Business Model: unknown
Revenue: 68M
Employees: 50
Industry: Biopharma
Hengrui Therapeutics is engaged in the development and commercialization of cancer therapies.
Business Model: unknown
Revenue: 6.3M
Employees: 28
Industry: Biopharma
Immunome is a pharmaceutical company that develops novel drugs for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 40
Industry: Biopharma
Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&a;D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Nevakar is a New Jersey-based biopharmaceutical company that develops and commercializes ophthalmic and injectable products for the healthcare sector.
Business Model: unknown
Revenue: 5M
Employees: 60
Industry: Biopharma
Epsilogen is a biotechnology firm that develops and commercializes immunoglobulin E antibodies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Aeovian Pharmaceuticals is a biopharmaceutical company that focuses on developing innovative therapeutic treatments. Aeovian Pharmaceuticals is headquartered in Walnut Creek, California.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification. Its protein interrogation powered by nanoneedles enables early disease detection, prognostic monitoring, and biomarker discovery on a single chip. .
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Reviva develops is a California-based clinical-stage biopharmaceutical company that develops and commercialize therapeutics for inflammatory and cardiovascular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 5
Industry: Biopharma
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications. Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn&s;s Disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Iconic Therapeutics develops and commercializes biologics-based therapeutics for the treatment of macular degeneration and cancer.
Business Model: unknown
Revenue: 12M
Employees: 40
Industry: Biopharma
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines that brings effectiveness, safety, tolerability, and advanced production capabilities to the market. Curevo&s;s lead product, a sub-unit Zoster (Shingles) Vaccine, has completed Phase I (90 subject trial). Results are showing a promising safety profile and the desired immune responses. They are targeting a unique position in the $7B Varicella Zoster Virus vaccine market.
Business Model: unknown
Revenue: 1.8M
Employees: 30
Industry: Biopharma
Elpiscience is a China-based clinical-stage biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 2M
Employees: 35
Industry: Biopharma
ImmuneOnco is a biotechnology company that develops therapies to treat cancer, infectious and autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Xontogeny is a biotechnology aggregator that focuses on the development of life science technologies to treat patients with serious diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
21st.BIO is a bioproduction startup that assists bioindustrial companies in scaling up from molecule innovation to large-scale production in order to meet market demands and thus advance the global green transition. It helps companies build a competitive manufacturing foundation allowing them to focus on succeeding in the market. Across multiple expression systems, 21st.BIO provides access to and optimizes high-performance strain platforms and production media improving yields and stability significantly.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Faron is a Finland-based biopharmaceutical company that researches and develops immunotherapies for the treatment of ARDS and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
Kinarus is a Switzerland-based pharmaceutical company that researches and develops novel drugs for ophthalmic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies for patients with chronic inflammatory diseases. The company&s;s AMTX-100 is bioengineered using human protein sequences that modulate the immune system by a natural process. Amytrx Therapeutics was founded in 2014 by Matthew A. Gonda and is based in Nashville, Tennessee.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Xuanzhu Biopharm is a biotechnology company that develops and markets novel drugs for the treatment of cardiovascular and metabolic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Amplifica is a California-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of hair loss.
Business Model: unknown
Revenue: 3M
Employees: 23
Industry: Biopharma
Boost Biomes is a biotechnology company that develops and markets microbiome-based fungicides and pesticides for the agriculture sector.
Business Model: unknown
Revenue: 2M
Employees: 15
Industry: Biopharma
Alterome is a California-based biopharmaceutical company that researches and develops alteration-specific therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 5.4M
Employees: 20
Industry: Biopharma
BioFeyn is improving what farmed fish eat. By optimizing marine ingredients so fish can get more of what they naturally get in the ocean, gains in efficiency and sustainability are improved across the industry. Through a specialized method of biodegradable nanoencapsulations, trace amounts of marine ingredients are surrounded by a shell of other naturally-derived compounds. This ensures better digestion, absorption, bioavailability, and delivery to target tissues in the animals to help them grow and remain healthy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
AMAG is a biotechnology company that develops novel therapeutics for the treatment of anemia, pregnancy complications and menopause disorders.
Business Model: unknown
Revenue: 327.8M
Employees: 440
Industry: Biopharma
Pieris is a Massachusetts-based biotechnology company that develops and commercializes anticalin-derived drugs for the treatment of cancer and respiratory diseases.
Business Model: unknown
Revenue: 55.3M
Employees: 130
Industry: Biopharma
Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found in reusable endoscopy systems. Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
CDx Diagnostics is a New York-based AI-assisted diagnostic platform that provides synthesizes computer imaging, molecular biology and 3D cytopathology to detect cancer.
Business Model: unknown
Revenue: 25M
Employees: 150
Industry: Biopharma
Shilpa Medicare is a manufacturer and supplier of pharmaceutical products for multiple sclerosis and immunosuppressant therapies.
Business Model: unknown
Revenue: 122.9M
Employees: 501 - 1000
Industry: Biopharma
Coya is a Texas-based clinical-stage biotechnology company that researches and develops regulatory T-cells therapies for neurodegenerative and autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10
Industry: Biopharma
Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases.
Business Model: unknown
Revenue: 20.9M
Employees: 406
Industry: Biopharma
Palisade Bio is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences, and technologies that will provide meaningful therapies for patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune-modulatory therapies that clear senescent cells and promote a healthy lifespan. Deciduous is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, a five-time biotech founder.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Acticor Biotech is a biopharmaceutical company that develops monoclonal antibody therapeutics for the treatment of thrombo-embolic diseases.
Business Model: unknown
Revenue: 2.5M
Employees: 16
Industry: Biopharma
OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, to interrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Ipsen is a France-based biopharmaceutical company that develops and commercializes generic medicines for the treatment of cancer and neurogenerative disease.
Business Model: unknown
Revenue: 2.9B
Employees: 5.7k
Industry: Biopharma
Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&a;D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Muna is a Denmark-based biopharmaceutical company that researches and develops therapies for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
Stallergenes Greer develops and commercializes allergy immunotherapy products.
Business Model: unknown
Revenue: 373.3M
Employees: 1.1k
Industry: Biopharma
Arecor is an England-based biopharmaceutical company that develops and commercializes therapeutic proteins and peptides properties enhancement for biotech companies.
Business Model: unknown
Revenue: 1.6M
Employees: 34
Industry: Biopharma
Minerva Neurosciences develops and commercializes clinical-stage products for the treatment of central nervous system diseases.
Business Model: unknown
Revenue: 41.2M
Employees: 9
Industry: Biopharma
Alpha Genesis is a provider of animal care and research programs that includes nonhuman primates in biomedical research and contract research.
Business Model: unknown
Revenue: 15M
Employees: 146
Industry: Biopharma
Credence MedSystems is a California-based medical device company that manufactures and supplies injectable drug delivery devices for the pharmaceutical industry.
Business Model: unknown
Revenue: 10.4M
Employees: 45
Industry: Biopharma
LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy. LIfT BioSciences was founded in 2016 and headquartered in London, England.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
LDR focuses on designing, developing and commercializing various surgical technologies for the treatment of patients suffering from spine disorders.
Business Model: unknown
Revenue: 200M
Employees: 562
Industry: Biopharma
LP Pharmaceutical is a biomedical firm that formulates and manufactures drugs for the central nervous system, cardiovascular diseases, and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 32
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
BlossomHill Therapeutics is a California-based biopharmaceutical company that develops drugs for the treatment of cancer and autoimmune disorders.
Business Model: unknown
Revenue: 1M
Employees: 5
Industry: Biopharma
Navega Therapeutics is a preclinical stage company developing gene therapies for neurological disorders (including pain) and ophthalmic diseases. Navega’s technology employs epigenetic regulation tools through a non-immunogenic platform. Our lead program is a gene therapy to treat chronic pain. We have achieved pain relief in four preclinical pain models via repression of Nav1.7, a pain gatekeeper gene. Our approach is completely different from previous attempts. Rather than targeting the protein or the RNA, which undergo extensive turnover, we target the DNA of Nav1.7 to downregulate the channel without introducing permanent mutations in the genome. Our co-lead program is a mutation agnostic approach to tackle all forms of retinitis pigmentosa, preventing neuronal degeneration in the eye through in vivo cellular reprogramming. We secured more than $8M in grants from the NIH and CIRM and with a strong IP portfolio internally developed and in-licensed from UCSD, we are well poised to create the medicines of the future.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Inmagene is a biopharmaceutical company that develops and commercializes immunology-related therapeutics for the healthcare industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Sling Therapeutics is a Michigan-based biopharmaceutical company that researches and commercializes oral small molecules for the treatment of thyroid eye disease.
Business Model: unknown
Revenue: 1M
Employees: 4
Industry: Biopharma
Vivasure is an Ireland-based medical device company that manufactures and markets polymer implants and delivery systems for cardiology and radiology applications.
Business Model: unknown
Revenue: 5M
Employees: 39
Industry: Biopharma
Inversago Pharma is a Canada-based biotechnology company that researches and develops CB1 antagonist drugs for the treatment of lung fibrosis and diabetic kidney diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 30
Industry: Biopharma
Samsara engages in the discovery and development of compounds that address the primary molecular causes of disease initiation and progression.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Alios BioPharma develops novel antiviral therapies for the treatment of oncology and respiratory diseases.
Business Model: unknown
Revenue: 15.7M
Employees: 40
Industry: Biopharma
Egalet develops, manufactures and commercializes non-narcotic and abuse-discouraging products for the treatment of chronic pain.
Business Model: unknown
Revenue: 82.8M
Employees: 127
Industry: Biopharma
Aspargo Laboratories is a developer of an oral spray that treats erectile dysfunction.Spray formulation offers convenient drug administration, flexible-dose titration, and accessibility for patients with dysphagia (trouble swallowing). The company develops patient-focused solutions and medicines by combining their innovative science and technology. Its initial product candidate is a proprietary oral suspension spray formulation of sildenafil citrate, the active ingredient in VIAGRACurrently, it has approved for sale in 9 European countries and 8 Latin American countries, with pending approvals in Portugal, Mexico, Italy, Czech Republic, Slovak Republic, Greece, Australia, and China. Applications for approval are planned for Croatia, France, Germany, and Austria.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Invectys is a Texas-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 4.2M
Employees: 35
Industry: Biopharma
PanOptica develops and commercializes ocular therapies and eye drops for the treatment of ophthalmic diseases.
Business Model: unknown
Revenue: 8.9M
Employees: 100
Industry: Biopharma
Nawah Scientific is a life science company that provides on-demand scientific research and analytical services for the pharmaceutical sector.
Business Model: unknown
Revenue: 1.8M
Employees: 23
Industry: Biopharma
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.
Business Model: unknown
Revenue: 74.3M
Employees: 220
Industry: Biopharma
Marius Pharmaceuticals is a biopharmaceutical company that develops oral testosterone replacement therapy to bring novel treatments to a range of diseases with unmet medical needs. The company&s;s solutions overcome many of the problems associated with currently approved products and their proprietary delivery technology has reached optimal absorption with all meal types resulting in a higher bioavailability, providing men suffering from low testosterone with safe and efficacious treatment. The company was founded in 2017 and headquartered in Raleigh, North Carolina.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Oisin Biotechnologies is a biopharmaceutical company that develops therapies for age-related diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 14
Industry: Biopharma
Galil Medical designs and develops novel minimally-invasive cryotherapy solutions for the cryosurgical ablation of benign tissue and cancerous tumors.
Business Model: unknown
Revenue: 22M
Employees: 60
Industry: Biopharma
Nanotherapeutics researches, discovers, develops, manufactures and distributes proteins, antibodies, viral vaccines and gene therapy drug products.
Business Model: unknown
Revenue: 20M
Employees: 55
Industry: Biopharma
Intabio develops a microfluidic platform that provides molecular identification and glycoform analytics solutions for the biotherapeutic industry.
Business Model: unknown
Revenue: 2.5M
Employees: 48
Industry: Biopharma
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess. It was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into corticosteroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism and to revolutionize the treatment of autoimmune and inflammatory conditions. Its lead product, SPI-62, is an oral, small molecule, a novel treatment designed to target the source of active intracellular corticosteroids in key tissues. The company was founded in 2013 by David A. Katz and is based in Portland, Oregon, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Celtaxsys is a clinical stage drug development company focused on developing novel therapies for inflammatory diseases.
Business Model: unknown
Revenue: 11.4M
Employees: 20
Industry: Biopharma
Bloom is a Fribourg-based utility company that produces and supplies biomass-based petrochemicals and transportation fuels for the commercial sector.
Business Model: unknown
Revenue: 6M
Employees: 10
Industry: Biopharma
Naurex discovers, develops and commercializes therapies for the treatment of psychiatric and neurologic disorders.
Business Model: unknown
Revenue: 2M
Employees: 50
Industry: Biopharma
Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzyme engineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Biopharma
Cirius is a clinical-stage pharmaceutical company that researches and develops novel therapeutics for the treatment of liver and metabolic diseases.
Business Model: unknown
Revenue: 3M
Employees: 11
Industry: Biopharma
Kythera develops novel prescription products for esthetic medicine.
Business Model: unknown
Revenue: 1.2M
Employees: 106
Industry: Biopharma
GENFIT is a France-based late-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of metabolic and inflammatory diseases.
Business Model: unknown
Revenue: 96.9M
Employees: 122
Industry: Biopharma
Celator Pharmaceuticals researches and distributes therapies to treat cancer, leukemia and small cell lung cancer.
Business Model: unknown
Revenue: 1
Employees: 25
Industry: Biopharma
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company dedicated to accelerating the development of bio-medicine and significantly reducing manufacturing costs. Their core strengths are molecular design, process design, drug product design and manufacturing plant design.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Teon Therapeutics is a California-based biopharmaceutical company that develops and commercializes small molecule therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 3.8M
Employees: 12
Industry: Biopharma
D2G Oncology is a biotechnology company that specializes in developing drugs to genotypes to transform precision cancer therapeutics. The company was founded by Jonathan MacQuitty in 2018 and is headquartered in Mountain View, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
101 Therapeutics is a Phase II pharmaceutical company on a mission to cure infectious diseases by targeting the pathology not the the pathogen. After a successful Phase I safety trial, 101 Therapeutics is conducting a Phase II efficacy trials for its targeted COVID-19 therapy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Matterhorn is a biotechnology company focusing on the discovery of cellular therapies targeting the MR1 molecule. MR1 presents cancer-specific metabolites on the surface of cancer cells that are recognized and killed by T cells bearing a MR1-specific T cell receptor.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Sinogen Biopharma is founded with a vision to bridge China&s;s biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
BioSapien is a California-based biotechnology company that researches and develops novel biodegradable implantable products for cancer chemotherapy treatments.
Business Model: unknown
Revenue: 1M
Employees: 18
Industry: Biopharma
TOT is a clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of cancer.
Business Model: unknown
Revenue: 6.5M
Employees: 332
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Aptevo is a biotechnology company that develops and commercializes novel immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 6.8M
Employees: 50
Industry: Biopharma
PolyPid is an Israel-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of inflammation and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 75
Industry: Biopharma
Gene Techno is a pharmaceutical company that develops molecular therapeutics and antibody drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
SolasCure is an England-based biotechnology company that develops wound cleaning products for health care professionals to treat patients with chronic wounds.
Business Model: unknown
Revenue: 2M
Employees: 10
Industry: Biopharma
Mast Therapeutics is engaged in development and commercialization of novel therapies for the treatment of life-threatening respiratory diseases.
Business Model: unknown
Revenue: 376k
Employees: 20
Industry: Biopharma
Inflazome is a biotech company that develops and commercializes molecular-targeted drug therapies for the treatment of inflammatory diseases.
Business Model: unknown
Revenue: 1.7M
Employees: 7
Industry: Biopharma
Rigenerand is an Italy-based biomedical company that provides cell-based biotechnology solutions such as 3-D cell cultures and cancer gene therapies for the biotech industry.
Business Model: unknown
Revenue: 2.1M
Employees: 20
Industry: Biopharma
Synaptogenix is a New York-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurodegenerative disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 4
Industry: Biopharma
Exonics is a biotechnology company that focuses on provding gene repair therapies for genetic neuromuscular diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 11 - 50
Industry: Biopharma
Kither Biotech is an Italy-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of pulmonary diseases.
Business Model: unknown
Revenue: 5M
Employees: 12
Industry: Biopharma
Ocuphire Pharma is a Michigan-based clinical-stage ophthalmic biopharmaceutical company that develops and commercializes therapies for the treatment of eye disorders.
Business Model: unknown
Revenue: 2M
Employees: 8
Industry: Biopharma
Genprex is a biopharmaceutical company that researches, develops, and commercializes nanovesicle therapies for the treatment of cancer.
Business Model: unknown
Revenue: 45M
Employees: 20
Industry: Biopharma
Arrivo BioVentures is a biopharmaceutical development company that focuses on identifying biologics and small molecules to improve patient care.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Cytocom is a Colorado-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of autoimmune and cancer diseases.
Business Model: unknown
Revenue: 262.9k
Employees: 9
Industry: Biopharma
PRISM Pharma Provides Biopharmaceutical company, focuses on the development of therapeutic compounds for the treatment.
Business Model: unknown
Revenue: 53.2M
Employees: 634
Industry: Biopharma
New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Iksuda is an England-based biotechnology company that develops and commercializes antibody therapies for the treatment of cancer.
Business Model: unknown
Revenue: 2.5M
Employees: 16
Industry: Biopharma
Sunshine Biopharma is a Canada-based pharmaceutical company that develops and markets oncology and antiviral drugs for the treatment of cancer and COVID-19.
Business Model: unknown
Revenue: 490.9k
Employees: 3
Industry: Biopharma
EyeD Pharma develops and markets ophthalmic drugs for treating eye-related diseases.
Business Model: unknown
Revenue: 12M
Employees: 38
Industry: Biopharma
Discover Echo is a California-based microscopy and imaging company that develops and manufactures hybrid microscopes for biological research and pathologies.
Business Model: unknown
Revenue: 12.5M
Employees: 50
Industry: Biopharma
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer&s;s disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing their platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - they have established a product pipeline with first/best in class potential. Through development and commercialization partnerships they have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
PhagoMed is an Austria-based biotechnology company that develops and commercializes therapies for the treatment of bacterial infections.
Business Model: unknown
Revenue: 3.2M
Employees: 30
Industry: Biopharma
CanSino is a biotechnology company focuses on the development & commercialization of vaccine products, including one for COVID-19.
Business Model: unknown
Revenue: 284.1M
Employees: 740
Industry: Biopharma
SpIntellx is a Pennsylvania-based AI platform that offers drug discovery, clinical trial optimization, workflow management, and analytics for the healthcare sector.
Business Model: unknown
Revenue: 1.1M
Employees: 14
Industry: Biopharma
Azenta is a Kentucky-based company that manufactures and supplies automation, vacuum and instrumentation equipment for sectors including semiconductor and life sciences.
Business Model: unknown
Revenue: 555.5M
Employees: 3k
Industry: Biopharma
Epimab is a China-based biopharmaceutical company that develops novel bi-specific antibody therapeutics for the treatment of cancer, inflammatory and autoimmune diseases.
Business Model: unknown
Revenue: 9.3M
Employees: 46
Industry: Biopharma
Elastrin is a South Carolina-based biotechnology company that develops elastin fiber, calcified tissue and organ supple for the treatment of life-threatening diseases.
Business Model: unknown
Revenue: 4M
Employees: 10
Industry: Biopharma
Soteria Biotherapeutics is a California-based immuno-oncology company that develops bispecific T-cell engagers to treat patients with solid tumors.
Business Model: unknown
Revenue: 5.5M
Employees: 40
Industry: Biopharma
BMS is a New York-based biopharmaceutical firm that develops and commercializes medicines for treating patients prevail over serious diseases.
Business Model: unknown
Revenue: 47B
Employees: 32.2k
Industry: Biopharma
AnaCardio is a Sweden-based clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of heart failure.
Business Model: unknown
Revenue: 2.3M
Employees: 20
Industry: Biopharma
Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.
Business Model: unknown
Revenue: 76.4M
Employees: 432
Industry: Biopharma
Yuyao Biotech is a biotechnology company focusing on major unmet clinical drug needs, led by artificial intelligence and modern drug creation technology. They treat hematological tumors, neurodegenerative diseases, and autoimmune diseases. They focus on innovation to benefit human health.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Mabworks is a biotechnology company that researches and develops gene engineering antibody drugs for the healthcare industry.
Business Model: unknown
Revenue: 60M
Employees: 120
Industry: Biopharma
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company&s;s rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn&s;s disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
A-Mansia is a microbiome company focused on developing products based on the properties of akkermansia muciniphila bacterium.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Ocera is a biopharmaceutical company that focuses on the development and commercialization of ornithine phenylacetates.
Business Model: unknown
Revenue: 609k
Employees: 19
Industry: Biopharma
DiaMedica Therapeutics is a Minnesota-based biopharmaceutical company that develops novel therapeutics for the treatment of neurological disorders and kidney diseases.
Business Model: unknown
Revenue: 4.7M
Employees: 10
Industry: Biopharma
Cardiorentis is a biopharmaceutical company designed for drug development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Hero Patch is an online drug delivery platform that allows users to buy monoclonal antibodies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
REGiMMUNE develops novel and proprietary products focused on therapeutic areas.
Business Model: unknown
Revenue: 5.5M
Employees: 58
Industry: Biopharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Escalier Biosciences develops topical and oral therapeutics for the treatment of psoriasis and other autoimmune diseases.
Business Model: unknown
Revenue: 1M
Employees: 241
Industry: Biopharma
Resverlogix is a biotechnology company that researches, develops and commercializes BET inhibitors for the treatment of chronic diseases.
Business Model: unknown
Revenue: 3.2M
Employees: 27
Industry: Biopharma
Ellipse Technology develops minimally invasive, remote controlled implants for limb lengthening and scoliosis treatment.
Business Model: unknown
Revenue: 32.7M
Employees: 346
Industry: Biopharma
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biorchestra is a South Korea-based biotechnology company that develops and commercializes RNA therapies for the treatment of neurodegenerative and inflammatory diseases.
Business Model: unknown
Revenue: 3M
Employees: 72
Industry: Biopharma
Civitas develops pulmonary delivery therapies.
Business Model: unknown
Revenue: 43.5M
Employees: 695
Industry: Biopharma
AmacaThera is a biotechnology company that develops and commercializes hydrogel-based nonopioid pain therapeutic products for post-surgery.
Business Model: unknown
Revenue: 0 - 100000
Employees: 25
Industry: Biopharma
GRI Bio engaged in providing treatment for lung diseases.
Business Model: unknown
Revenue: 4.7M
Employees: 23
Industry: Biopharma
KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncology and infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN&s;s clinically-validated platforms are uniquely disease-mechanism and indication agnostic.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Pharma Two B is a biotechnology company that develops and commercializes novel therapeutics for the treatment of Parkinson's diseases.
Business Model: unknown
Revenue: 8M
Employees: 10
Industry: Biopharma
TFF is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic respiratory diseases.
Business Model: unknown
Revenue: 195k
Employees: 4
Industry: Biopharma
4B Technologies is a biotech company that develops novel medicines for neurodegenerative diseases and neurological injuries. Its drug development focuses on reliving pain symptoms from nervous system diseases such as stroke and glaucoma, enabling healthcare professionals to prescribe more effective treatments to their patients. The company was founded in 2017 and is based in Suzhou, China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
OncoQuest is a pharmaceutical company that focuses on developing and commercializing products for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
ZIVO Bioscience specializes in the study, development and commercialization of nutritional compounds and bioactive molecules.
Business Model: unknown
Revenue: 2.5M
Employees: 10
Industry: Biopharma
AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Eikonoklastes is an Ohio-based preclinical-stage biopharmaceutical company that researches and develops tissue factor immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
Nuevocor is a Singapore-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of heart diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
Tavotek is a Pennsylvania-based biopharmaceutical company that researches and develops therapeutic medicines for oncology, autoimmune, and inflammatory diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Utilex engages in development and commercialization of immunotherapy for oncology diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Caristo is an England-based medical imaging company that develops cardiovascular image analysis technology to detect and quantify inflammation in the coronary arteries.
Business Model: unknown
Revenue: 3.1M
Employees: 26
Industry: Biopharma
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
ADC Therapeutics is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers.
Business Model: unknown
Revenue: 137.9M
Employees: 312
Industry: Biopharma
Innogen is a China-based biopharmaceutical company that develops and commercializes novel drugs for the treatment of diabetes, cardiovascular, and CNS diseases.
Business Model: unknown
Revenue: 5M
Employees: 15
Industry: Biopharma
Switchback Systems is an early-stage startup engaged in the rapid development of a highly scalable DNA synthesis platform. It focuses on dramatic minimization of time, cost, and waste, for utilization in a wide range of nucleic acid applications. The company was founded in 2019 by Mary Noe.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biomarck is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer, COPD and ARDS.
Business Model: unknown
Revenue: 8M
Employees: 20
Industry: Biopharma
Porton Bio is a China-based biopharmaceutical company that provides gene and cell therapy CDMO services for healthcare organizations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Quercis is Switzerland-based biopharmaceutical company that develops and commercializes drugs for the treatment of cancer.
Business Model: unknown
Revenue: 3.5M
Employees: 20
Industry: Biopharma
Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare. They have developed a scaffold that removes the need for cadaver-sourced material used in breast reconstruction surgery, making procedures safer and cheaper. Plcoskin’s scaffolds are made with synthetic PCL, a biodegradable material that is commonly used to create surgical sutures. Unlike competitors&s; products that remain in the body for a lifetime, Plcoskin’s PCL scaffolds are absorbed and replaced with the recipient’s own natural tissues, minimizing the possibility of long-term side effects. As they do not contain any dangerous chemicals, they are also 50% safer than cadaver-sourced scaffolds. Costs for reconstructive breast surgery are brought down by 40% to only $3 thousand per breast. Furthermore, much less handling time is required, reducing average surgery durations from an hour and a half to only 30 minutes. The mesh design of the scaffolds mitigates the need for an additional follow-up reconstructive surgery, something that is common when using cadaver-sourced scaffolds. Plcoskin has also developed Youlief, a cosmeceutical product &a; therapeutic device pipeline that helps fund R&a;D for their medical devices. Youlief is available in the US, Europe, Taiwan, Singapore and Japan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Highlight Therapeutics is a Spain-based biotechnology firm that develops and commercializes RNA therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Traitology is engaged in the development of novel traits in soybean and other key crops of global importance.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Citryll is a pharmaceutical firm that researches, develops and commercializes therapeutics for the treatment of NETosis and NETs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company&s;s drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently. It was founded in 2017 and is headquartered in San Diego, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Protego Biopharma is a California-based biotechnology company that develops and commercializes therapeutics for the treatment of protein misfolding diseases.
Business Model: unknown
Revenue: 4.2M
Employees: 50
Industry: Biopharma
Abterra Biosciences provides technologies that use the latest in next-generation sequencing, mass spectrometry, and machine learning methods to comprehensively map the antibody response, and rapidly identify better therapeutic antibodies. Abterra Biosciences assembles an interdisciplinary team of data scientists and biologists to reimagine the development of antibody therapeutics. Alicanto, a novel antibody discovery platform developed by Abterra Biosciences, identifies target-specific antibodies in serum. It identifies high-affinity antibodies without the need for time-consuming and inefficient cell selection, fusions, or cloning.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
AxoSim develops a Multi-Organ-Chip platform that offers drug research, development and testing solutions to the pharmaceutical sector.
Business Model: unknown
Revenue: 5.2M
Employees: 25
Industry: Biopharma
Ustar is a high-tech biotechnology company dedicated to the development, production, and sale of POCT molecular diagnostic products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Winner of a 2022 Earthshot Prize Notpla is a packaging company that created a material made from seaweed and plants that disappears naturally.
Business Model: unknown
Revenue: 2.3M
Employees: 31
Industry: Biopharma
AlgaeCytes Limited has developed a proven innovative approach to the production of Omega 3 fatty acids, which are polyunsaturated fatty acids used in numerous bodily functions, such as controlling blood clotting and building cell membranes in the brain. Associated with many health benefits, including protection against heart disease and possibly stroke, new studies are identifying potential benefits for a wide range of conditions including cancer, inflammatory bowel disease and other auto-immune diseases such as lupus and rheumatoid arthritis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
OnQuality is a China-based biopharmaceutical company that develops and commercializes medicinal drugs for the treatment of cancer.
Business Model: unknown
Revenue: 3.1M
Employees: 18
Industry: Biopharma
MAIA Pharmaceuticals company that identifies, develops, manufactures, and markets innovative and niche generic products. It specializes in the fields of providing injectables, niche generic, diagnostics, hormones, and oncology. It was founded in 2013 and headquartered in Princeton, New Jersey.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
PredictImmune develops and commercializes anti-inflammatory drugs for the treatment of immune-mediated inflammatory diseases.
Business Model: unknown
Revenue: 5M
Employees: 11 - 50
Industry: Biopharma
Octarine is a biopharmaceutical firm that researches and develops cannabinoid and psilocybin derivatives to healthcare industries.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Chime Biologics is a China-based contract development and manufacturing organization that provides cell line development and drug product manufacturing services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 30
Industry: Biopharma
LabMinds is a Massachusetts-based company that manufactures and markets AI-integrated lab automation robotic systems for sectors including pharmaceutical and healthcare.
Business Model: unknown
Revenue: 6.5M
Employees: 22
Industry: Biopharma
Acacia Pharma is an England-based pharmaceutical company that develops and commercializes novel products for cancer chemotherapy.
Business Model: unknown
Revenue: 211k
Employees: 72
Industry: Biopharma
PHEMI is a data management platform that provides data privacy, governance, and related solutions for healthcare organizations.
Business Model: unknown
Revenue: 1M
Employees: 37
Industry: Biopharma
Brinter is a revolutionary modular 3D bioprinter for global markets. A comprehensive 3D bio solution offering variable printing modalities in a single printing platform. Innovating medical, pharmaceutical, and life science industries. Brinter™ will extend the human life span and relieve famine in the world. Brinter™ is a revolutionary modular 3D-bio printer for global markets designed for medical, pharmaceutical, and life science industries. Using different bio inks, Brinter™ can be used to print anything from living tissues and transplantable organs to personalized medicine and food. Built alongside globally recognized medical facilities, educational institutes, and research centers. Our partners and clients are on the bleeding edge of bio innovations. Modular technology allows for infinite future modules for new bio applications, client ideas, and improvements. Revolutionize your industry with Brinter™ bioprinters.
Business Model: unknown
Revenue: 143k
Employees: 13
Industry: Biopharma
Exonate focuses on the discovery and development of treatment for retinal neovascular diseases.
Business Model: unknown
Revenue: 1M
Employees: 18
Industry: Biopharma
Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Eton Pharma is a pharmaceutical company that researches, develops and commercializes injectables, oral liquids and ophthalmics.
Business Model: unknown
Revenue: 18.8M
Employees: 20
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&a;D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Lycera discovers and develops small-molecule immunomodulators for the treatment of autoimmune diseases and cancer.
Business Model: unknown
Revenue: 10M
Employees: 29
Industry: Biopharma
Augustine Therapeutics is a Belgium-based biotechnology company that develops and commercializes medicines for the treatment of neuromuscular diseases.
Business Model: unknown
Revenue: 400k
Employees: 6
Industry: Biopharma
Philogen is a biotechnology company that develops drugs for the treatment of angiogenesis-related disorders.
Business Model: unknown
Revenue: 8.5M
Employees: 70
Industry: Biopharma
Biomolecules are the next bits of the 21st century. So we&s;re developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We&s;re enabling the storage and access to the whole data universe—digital and biological—forever so that we don&s;t have to delete or dispose of anything ever again.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
CytRx is a biopharmaceutical research and development company specializing in oncology. The CytRx oncology pipeline is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin. CytRx has initiated an international Phase 2b clinical trial as a treatment for soft tissue sarcomas, has completed its Phase 1b/2 clinical trial primarily in the same indication, and has initiated a Phase 1b pharmacokinetics clinical trial in patients with metastatic solid tumors and a Phase 1b study of aldoxorubicin in combination with doxorubicin in patients with advanced solid tumors. The Company is initiating a Phase 3 pivotal trial under a special protocol assessment (SPA) with aldoxorubicin as a therapy for patients with soft tissue sarcomas whose tumors have progressed following treatment with chemotherapy. CytRx is expanding its pipeline of oncology candidates based on a novel linker platform technology that can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites. The Company also has rights to two additional drug candidates, tamibarotene and bafetinib. The Company completed its evaluation of bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), and plans to seek a partner for further development of bafetinib, and is evaluating further development of tamibarotene.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Canopy Biosciences is biotechnological company that provides products and services for gene editing and personalized medicine. The gene editing technology is called TUNR and targets translation elongation by inserting polyA tracks into targeted coding regions of the genome. This change then decreases the levels of mRNA transcribed from the gene and therefore suppresses protein expression. It was initially developed by Professor Sergej Djuranovic at Washington University School of Medicine and Professor Rachel Green from Johns Hopkins University. Canopy Biosciences was formed in 2016 and is headquartered in Saint Louis, Missouri.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly. The core of our technology is a novel biopolymer which is used as a platform for passive transdermal drug delivery of small molecules and drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Kinomica is a proteomic-data science and diagnostics company that develops early-stage precision medicine for the treatment of tumors and cancers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 25
Industry: Biopharma
Amal Therapeutics develops and commercializes peptide-based therapeutic vaccines for the treatment of cancer.
Business Model: unknown
Revenue: 150M
Employees: 57
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Cytovant is a biotechnology company that develops and commercializes cell-based therapies for the treatment of cancer and orphan diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 36
Industry: Biopharma
Beihai Bio is a biotechnology and pharmaceutical company that researches, develops, and produces safe anti-cancer drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Lpath is focused on the discovery and development of bioactive lipid-targeted therapeutic antibodies for treating and diagnosing human diseases.
Business Model: unknown
Revenue: 60.9M
Employees: 213
Industry: Biopharma
GRAIL is a California-based biotechnology company that researches and develops organ-specific screening tests for the early detection of cancer.
Business Model: unknown
Revenue: 50M
Employees: 750
Industry: Biopharma
Lipidio is a biotechnology company that develops drugs to reduce body fat.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
OccuRx is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of fibrotic and inflammatory diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10
Industry: Biopharma
Bioline AgroSciences is an England-based producer and marker of crop management products for the agriculture industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Symphogen is a biopharmaceutical company that researches and develops antibody therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 25.1M
Employees: 108
Industry: Biopharma
Viron Therapeutics Holdings Inc. is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid 19, is under FDA review.
Business Model: unknown
Revenue: 16.6M
Employees: 76
Industry: Biopharma
InterAx is a Switzerland-based AI-powered platform that provides drug discovery and development solutions for the pharmaceutical sector.
Business Model: unknown
Revenue: 7M
Employees: 25
Industry: Biopharma
Allecra Therapeutics develops and commercializes novel antibiotics for the treatment of multi drug-resistant bacterial infections.
Business Model: unknown
Revenue: 1M
Employees: 9
Industry: Biopharma
Biofrontera is a Germany-based biopharmaceutical company that develops and commercializes dermatological medications and medical cosmetics for the treatment of skin diseases.
Business Model: unknown
Revenue: 27.7M
Employees: 70
Industry: Biopharma
BioElectron is a biotechnological company that focuses on researching and developing therapeutics for the treatment of genetic and acquired diseases.
Business Model: unknown
Revenue: 10M
Employees: 58
Industry: Biopharma
PLx Pharma develops aspirin drugs for the treatment of cardiovascular diseases.
Business Model: unknown
Revenue: 4.5M
Employees: 20
Industry: Biopharma
GBB is a Hong Kong-based biotech company that provides AI-powered bioprocessing services for applications such as biopharmaceutical and synthetic biology.
Business Model: unknown
Revenue: 2M
Employees: 30
Industry: Biopharma
Enyo Pharma develops and commercializes small molecule therapeutics for the treatment of oncology, metabolic and infectious diseases.
Business Model: unknown
Revenue: 2M
Employees: 20
Industry: Biopharma
Eleva is a Denmark-based biotechnology company that researches and develops enzymes, antibodies and fusion toxin products for the pharmaceutical sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connects to our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Zurex Pharma operates a novel antimicrobial technology platform, that focus on surgical site wounds and catheter-related infections.
Business Model: unknown
Revenue: 9.4M
Employees: 40
Industry: Biopharma
Silenseed is a clinical stage biopharmaceutical company that develops proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The company’ novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company’s pipeline are pancreatic cancer, prostate cancer and certain brain cancers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 57
Industry: Biopharma
ILIAS is a biotechnology company that develops and commercializes exosome-based therapeutics for the treatment of inflammatory and metabolic diseases.
Business Model: unknown
Revenue: 4.9M
Employees: 20
Industry: Biopharma
NeuroVia focuses on developing treatments for rare genetic neurological diseases.
Business Model: unknown
Revenue: 5M
Employees: 75
Industry: Biopharma
OPM Biosciences is a biotechnology company that develops and commercializes cell culture medium for the production of biomedicines.
Business Model: unknown
Revenue: 4M
Employees: 35
Industry: Biopharma
4SC discovers and develops small molecule drugs for the treatment of cancer and autoimmune disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Bigfish is a provider of reagent research and development solutions for the laboratory sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Lakewood-Amedex is a clinical-stage pharmaceutical company that develops antimicrobial therapeutics for the treatment of infectious diseases.
Business Model: unknown
Revenue: 8M
Employees: 50
Industry: Biopharma
Scipio Bioscience is a biotechnology company that provides single-cell profiling sample preparation solutions for clinical sequencing applications.
Business Model: unknown
Revenue: 1.2M
Employees: 25
Industry: Biopharma
genedrive plc is a commercial stage medical devices company, targeting opportunities in infectious diseases, biosurveillance, and animal applications. Our Genedrive® system is positioned to offer lower cost, easy to use, point of need or clinic-based molecular diagnostic tests via a &s;razor/razor blade&s; business model across an increasing range of applications. Genedrive® is rapidly reconfigurable for specific assays and is suitable for use outside a traditional hospital setting. The system analyses nucleic acids from fresh or stored samples to provide rapid diagnosis and decision making.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Zensun develops and commercializes bio-therapeutic products for the treatment of cardiovascular disease and energy metabolism disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Delpor, Inc. develops drug delivery technologies that enable the sustained or pattern specific release of proteins, peptides, and small molecules.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Giiant Pharma is a Canada-based biotechnology company that develops and commercializes therapies for the treatment of inflammatory diseases.
Business Model: unknown
Revenue: 3M
Employees: 22
Industry: Biopharma
Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Tetragenetics is a Massachusetts-based drug discovery platform that offers solutions such as protein production and antibody discovery for the pharmaceutical sector.
Business Model: unknown
Revenue: 5M
Employees: 25
Industry: Biopharma
Adgero is a biopharmaceutical company that develops photodynamic therapeutics for the treatment of cutaneous oncology indications.
Business Model: unknown
Revenue: 12.5M
Employees: 20
Industry: Biopharma
Tetraphase is a biopharmaceutical company that develops and commercializes novel tetracyclines for bacterial infections and orphan diseases.
Business Model: unknown
Revenue: 7.9M
Employees: 66
Industry: Biopharma
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Polaris is a biotechnology company that develops and commercializes novel diagnosis therapies for the treatment of cancer.
Business Model: unknown
Revenue: 2M
Employees: 30
Industry: Biopharma
KeifeRx is a Virginia-based biotechnology company that develops tyrosine kinase inhibitors for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
ADC Bio is a UK-based biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer.
Business Model: unknown
Revenue: 4M
Employees: 38
Industry: Biopharma
Atriva is a Germany-based biopharmaceutical company that develops and commercializes antiviral therapeutics for the treatment of influenza and COVID-19.
Business Model: unknown
Revenue: 3.5M
Employees: 15
Industry: Biopharma
Aevi Genomic is a biopharmaceutical company that develops novel therapies for genetic disorders in adults and children.
Business Model: unknown
Revenue: 2.1M
Employees: 14
Industry: Biopharma
The IGI’s mission is to bridge revolutionary genome-editing tool development to affordable and accessible solutions in human health, climate, and agriculture. The IGI is working toward a world where genomic technology is routinely applied to treat genetic disease, enable sustainable agriculture, and help achieve a carbon-neutral economy.
Business Model: unknown
Revenue: 180.8k
Employees: 4
Industry: Biopharma
Nirogy is a Massachusetts-based biotechnology company that develops and commercializes small-molecule drugs for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
We believe that with the current technology society is on the verge of creating a bio-based economy. EV Biotech will evolve the chemical feedstock market by revolutionizing the methods of microbial cell factory strain engineering; hereby shifting the chemical market from petrochemical-based to biological-based chemical production. A revolutionary step for a more sustainable world.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Midatech is an England-based biotechnology company that researches and develops therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 779.7k
Employees: 22
Industry: Biopharma
CMAB is a China-based contract manufacturing organization that provides services such as process development and GMP manufacturing for the biopharmaceutical sector.
Business Model: unknown
Revenue: 10M
Employees: 250
Industry: Biopharma
InterveXion is an Arkansas-based biopharmaceutical company that develops and commercializes novel products for the treatment of addiction disorders.
Business Model: unknown
Revenue: 5M
Employees: 35
Industry: Biopharma
Potenza Therapeutics is a biotechnology company that develops immuno-oncology therapies.
Business Model: unknown
Revenue: 2M
Employees: 20
Industry: Biopharma
CEVEC is a Germany-based biopharmaceutical company that provides cell line development and viral vector manufacturing technologies for the life science industry.
Business Model: unknown
Revenue: 8.5M
Employees: 46
Industry: Biopharma
Cellect Biosciences focuses on developing technologies for the selection of stem cells in the field of regenerative medicine and stem cell therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 12
Industry: Biopharma
Symbiosis Pharmaceutical Services is a CMO that provides sterile manufacturing services to the pharmaceutical sector.
Business Model: unknown
Revenue: 5.8M
Employees: 90
Industry: Biopharma
ClostraBio is developing microbiome-modulating therapeutics to prevent the food allergies.
Business Model: unknown
Revenue: 1.5M
Employees: 12
Industry: Biopharma
ImmunoMet is a Texas-based biotechnology company that develops and commercializes therapies for the treatment of cancer and fibrosis diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 200
Industry: Biopharma
UAS Labs is a biotechnology company that researches and develops probiotics and antioxidants for the healthcare sector.
Business Model: unknown
Revenue: 85M
Employees: 230
Industry: Biopharma
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation &a; breakthrough therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Turing Pharmaceuticals is focusing on therapies for debilitating diseases.
Business Model: unknown
Revenue: 7M
Employees: 92
Industry: Biopharma
Vicore Pharma is a biotechnology company that develops and commercializes drugs for the treatment of fibrotic lung diseases.
Business Model: unknown
Revenue: 508k
Employees: 19
Industry: Biopharma
Snapdragon is a Massachusetts-based company that provides services such as chemical process development and GMP manufacturing for the pharmaceutical industry.
Business Model: unknown
Revenue: 10M
Employees: 74
Industry: Biopharma
Asarina Pharma is a drug development company that focuses on the development of sepranolone for the treatment of premenstrual dysphoric disorder.
Business Model: unknown
Revenue: 5.9M
Employees: 29
Industry: Biopharma
Intact Genomics is a world leader in large DNA fragment cloning and metagenomic technologies. We have dedicated scientists and state of the art equipment all housed in a modern facility, located in the Helix Center Biotech Incubator, next to Monsanto Headquarters, Donald Danforth Plant Science Center, and close to Washington University in St. Louis
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Flexus Biosciences engages in developing and commercializing therapeutics for cancer diseases.
Business Model: unknown
Revenue: 3M
Employees: 33
Industry: Biopharma
Surface is a biopharmaceutical company that focuses on the development and commercialization of therapeutics for ocular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Lactocore Group is a privately funded company led by a team of talented scientists and experienced managers whose mission it is to identify and develop transformative new medicines for mental and metabolic diseases. Lactocore’s expertise spans in silico drug discovery, peptide drug development, and behavioral neuroscience. A lean, efficient, semi-virtual company, Lactocore has a discovery group in Russia, U.S.-centered business development activities, and a network of global Clinical Research Organizations and collaborators, allowing it to conduct cutting-edge R&a;D at a fraction of the cost of traditional biotech companies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Thesan is a preclinical biopharmaceutical company engages in the development of novel therapeutics for disorders of the skin.
Business Model: unknown
Revenue: 4M
Employees: 6
Industry: Biopharma
Kinnate Biopharma is a California-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 70
Industry: Biopharma
NLS Pharmaceutics is a Switzerland-based biopharmaceutical company that researches and develops therapeutics for the treatment of central nervous system disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 6
Industry: Biopharma
Merck is a New Jersey-based global pharma company that develops and manufactures prescription medicines, novel vaccines, biologic therapies and animal health products.
Business Model: unknown
Revenue: 48.7B
Employees: 68k
Industry: Biopharma
MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
MarvelBiome researches and develops microbiome therapeutic solutions to healthcare sectors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
OncoHost is an Isreal-based biotechnology company that provides host response profiling solutions for cancer patients.
Business Model: unknown
Revenue: 2M
Employees: 12
Industry: Biopharma
Revere Pharmaceuticals is a biopharmaceutical company that researches and develops cellular immunotherapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Sitka Biopharma focuses on developing a nanoparticle platform to increase drug absorption of difficult-to-penetrate tissues in cancer treatments.
Business Model: unknown
Revenue: 4M
Employees: 18
Industry: Biopharma
LiveLeaf develops LiveXtract process, a method for harnessing the potency of reactive plant immunity. It provides LifeDrops, a solution to provide natural digestive health protection for families affected by poverty, poor infrastructure, and disaster; and Grazix and Rangix, which supply gut protective micronutrients absent from the processed dry feeds used in animal production. The company was incorporated in 2008 and is based in San Carlos, California.
Business Model: unknown
Revenue: 6.3M
Employees: 49
Industry: Biopharma
Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care. The NCP platform was pioneered by the lab of Professor Wenbin Lin at the University of Chicago. As a versatile technology platform, NCP components can be purposefully chosen to synergize with and enhance currently existing therapies. CPI products are especially potent in combination with checkpoint blockade inhibitors by increasing T cell infiltration into lowly immunogenic solid tumors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biosion is a biotech company focused on the development of biologics to treat resistant, relapsed, residual immune, and oncologic diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
EPICS Therapeutics develop novel therapeutic solutions for cancer, based on the highly innovative field of RNA epigenetics.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
MatriSys is a California-based biopharmaceutical company that develops and commercializes microbiome therapeutics for the treatment of skin conditions.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Biopharma
Zhimeng Biopharma is a pharmaceutical company that develops and commercializes novel therapies for treatment of hepatitis and CNS diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
GreenBone is an Italy-based healthcare company that develops and commercializes bone substitutes and related products for the treatment of trauma and osteomyelitis diseases.
Business Model: unknown
Revenue: 1.2M
Employees: 56
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Vitae provides compounding automation equipment for the pharmaceutical sector.
Business Model: unknown
Revenue: 12M
Employees: 1 - 10
Industry: Biopharma
NephroDI is a Pennsylvania-based pharmaceutical company that develops oral drugs to treat nephrogenic diabetes insipidus in children and pediatric orphan diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Pathalys is a North Carolina-based biopharmaceutical company that develops novel therapeutics for the treatment of chronic kidney diseases.
Business Model: unknown
Revenue: 1.5M
Employees: 10
Industry: Biopharma
BDD is a drug formulation company that offers troubleshooting, formulation development, in vitro and in vivo testing solutions.
Business Model: unknown
Revenue: 8M
Employees: 65
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform. The company&s;s drug discovery platform leverages deep learning, microbiome, and synthetic biology technologies, enabling drug companies to release the therapeutic power of the microbiome. It was founded in 2017 and is based in Allston, Massachusetts.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Sprint Bioscience AB offers a modular gene-to-lead drug discovery platform for fragment-based drug discovery, including protein expression and purification, fragment screening, X-ray crystallography, and expansion of fragments into a patented lead series. Sprint Bioscience is based in Stockholm, Sweden.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-κB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept in animal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Arno Therapeutics engages in the development of oncology therapeutics for cancer and life threatening diseases.
Business Model: unknown
Revenue: 4.6M
Employees: 4
Industry: Biopharma
CerSci is a biopharmaceutical company that provides non-opioid analgesic products for the treatment of sciatica and neuropathic pain syndromes.
Business Model: unknown
Revenue: 10M
Employees: 65
Industry: Biopharma
Eupry is a Denmark-based company that provides automated temperature monitoring and calibration solutions for hospitals, pharmacies, doctors, laboratories, and food producers.
Business Model: unknown
Revenue: 2M
Employees: 35
Industry: Biopharma
Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson&s;s Disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
AptaTargets is a biopharmaceutical company that focuses on developing therapeutic applications based on aptamer technology for acute stroke treatment.
Business Model: unknown
Revenue: 1M
Employees: 25
Industry: Biopharma
Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion. The Epigene Labs technology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches. With R&a;D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Oncomatryx is a biotechnology firm that researches and develops novel precision drugs for tumor stroma and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and is based in Warwick, Rhode Island, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis.The company has already identified a lead program and will partner with Evotec to develop novel molecules .
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Tarsius Pharma is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory ocular diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Symbiomix develops and commercializes novel therapies for the treatment of gynecological infections and bacterial vaginosis.
Business Model: unknown
Revenue: 4M
Employees: 126
Industry: Biopharma
SmartPharm is a biotechnology firm that researches and develops gene-encoded therapeutic for the treatment of cancer and orphan diseases.
Business Model: unknown
Revenue: 1.7M
Employees: 25
Industry: Biopharma
BSM is a bio-pharmaceutical company that develops and manufactures sterile drug products for clinical applications.
Business Model: unknown
Revenue: 16.2M
Employees: 150
Industry: Biopharma
CaroGen is a pharmaceutical company that researches and develops novel therapeutics for the treatment of infectious diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases.
Business Model: unknown
Revenue: 47.2B
Employees: 165
Industry: Biopharma
Engage Therapeutics is a biopharmaceutical company that develops a hand-held inhaler for the treatment of patients with epileptic seizures.
Business Model: unknown
Revenue: 1.2M
Employees: 15
Industry: Biopharma
ZYUS Life is a bio-pharmaceutical company that develops phyto-therapeutic compounds for the treatment of chronic diseases.
Business Model: unknown
Revenue: 27M
Employees: 70
Industry: Biopharma
Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide. The most advanced product developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients). Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
OmniSeq provides immuno-oncology diagnostic solutions for academic researchers and pharmaceutical companies.
Business Model: unknown
Revenue: 8.5M
Employees: 45
Industry: Biopharma
AyuVis is a Texas-based pharmaceutical company that develops and commercializes immunotherapies for the treatment of inflammation and microbial infection diseases.
Business Model: unknown
Revenue: 4M
Employees: 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
QRxPharma develops and commercializes biopharmaceutical products in Australia.
Business Model: unknown
Revenue: 2.4k
Employees: 11 - 50
Industry: Biopharma
Fluxion Biosciences provides cellular analysis tools for use in life science, drug discovery and diagnostic applications.
Business Model: unknown
Revenue: 4.4M
Employees: 120
Industry: Biopharma
Entheon develops and distributes serotonin and psychedelic substances products to healthcare sectors.
Business Model: unknown
Revenue: 482.4k
Employees: 1 - 10
Industry: Biopharma
Hunan Huateng Pharmaceutical Co., Ltd is a company committed to research and development, production and sales of high-end PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Huateng pharmaceuticals in Chinese, European and American countries have our own R &a; D and logistics center, the company has an excellent and efficient R &a; D and production and sales of a professional team. Fast for all global customers to provide professional, personalized and technical support of the one-stop service, can rapid and efficient delivery of products to the customers all around the world.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Dyadic develops, manufactures and sells enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical and industrial enzyme industries.
Business Model: unknown
Revenue: 190.2M
Employees: 7
Industry: Biopharma
Jeeva is a biotechnology firm that researches and develops ngs data analytics and cloud-based bioinformatics solutions to businesses.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape of powders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
AVATAMED is a drug screening platform that provides precision oncology and virtual clinical trial solutions for the healthcare sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Bionaut is a California-based biotechnology company that develops microscale robots to deliver small molecule therapies for the treatment of central nervous system disorders.
Business Model: unknown
Revenue: 3M
Employees: 30
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
GenNext Technologies is a platform that provides instrumentation, software, and services to structural biology researchers within the biopharmaceutical industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Metabomed is a biotechnology company that discovers, develops and commercializes small molecule drugs for the treatment of cancer.
Business Model: unknown
Revenue: 3.8M
Employees: 20
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Synplogen is a start-up company that brings together unique DNA synthesis technologies that Kobe University and others have been developing for nearly 10 years. Utilizing state-of-the-art genetic engineering, information science, and robotics, Synplogen have the technology to synthesize high-throughput.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ResBiotic is an England-based nutrition company that manufactures and sells health care supplements for individuals and retailers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
MavenView is a software company founded in 2015 to advance research out from the lab and into commercialization more quickly and efficiently by mapping science and technology related IP to potential commercialization partners. Since then the MavenView platform has evolved into a decision and strategic support system that informs multiple use cases including: The MavenView platform gives business strategists, researchers and IP professionals insight into the strengths, weaknesses, opportunities, and threats in a particular technology space by identifying trends, top organizations, experts, funding and patenting activity, so that they are able to strategically plan, predict, and execute with confidence.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Levicept develops biological therapy for the treatment of chronic pain.
Business Model: unknown
Revenue: 5.3M
Employees: 27
Industry: Biopharma
Soricimed researches, develops and distributes drugs for the treatment of cancer and tumor.
Business Model: unknown
Revenue: 4.5M
Employees: 146
Industry: Biopharma
Founded in Suzhou Industrial Park since 2009, Lisure Science (Suzhou) Co., Ltd is a national hi-tech enterprise. Currently, Lisure has set up with one 20,000㎡production facility (Shengpu) and one 3,000㎡application center (Biobay) . Lisure Science is a professional provider of technology and products in biopharmaceutical separation and purification. They focus on the development and amplification of separation and purification process, selection and optimization of separation media, customization of separation and purification system, design and implementation of separation and purification projects, providing customer with total solution. In biological production process like filtration and separation, chromatography and purification, on-line buffer mixing, they can also provide automated, intelligent and personalized solution. Their products and services cover the whole biopharmaceutical process from medicine discovery, pilot scale-up to scale production. Now, Lisure provides more than 1000 biopharmaceutical enterprises and R&a;D institutions with products and services in monoclonal antibody, recombinant protein and bloods products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Bioaesthetics is a North Carolina-based biotechnology firm that develops and commercializes tissue-engineered nipple-areolar complex graft to reconstruct breast cancer.
Business Model: unknown
Revenue: 2M
Employees: 32
Industry: Biopharma
Akelos is a New York-based biopharmaceutical company that researches and develops non-narcotic drugs for the treatment of neuropathic conditions.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
ExploRNA Therapeutics creates revolutionary advancements in the use of mRNA as a therapeutic platform, implements those ideas into distinct therapeutic programs, and provides technology, a therapeutic platform, and medicines to pharmaceutical partners.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Visto.bio desenvolve tecnologias, produtos e serviços para uma relação mais equilibrada entre pessoas e planeta
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Gilead develops and commercializes therapeutics for the treatment of liver, cancer, inflammatory, respiratory and cardiovascular diseases.
Business Model: unknown
Revenue: 27.5B
Employees: 14.4k
Industry: Biopharma
Ochre Bio is an England-based biotechnology firm that researches and develops RNA therapies for the treatment of chronic liver diseases.
Business Model: unknown
Revenue: 1M
Employees: 11
Industry: Biopharma
Covira Surgical engages in the development of drugs that modulate the biological activity of the gut microbiome&s;s resident bacteria. It is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira’s platform technology generated a lead asset (CS-0003) that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection. Covira’s approach is transformative to the field and the world is taking notice...in the 4th quarter of last year, Business Worldwide Magazine named Covira Among the 2021 - Top 20 Most Innovative Companies to Watch.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ICaPath is a biotech startup that engages in nanoparticle immunotherapy and immunodiagnostics.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Jennerex Biotherapeutics focused on the development and commercialization of targeted oncolytic immunotherapies for solid tumors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
PennAlt is a pharmaceutical company that focuses on neurological disorders.The company&s;s products specialize in the treatment of disorders related to brain, spine and the nerves by providing medical marijuana at an appropriate and consistent dosage, enabling patients to alleviate pain and suffering and recover from their disorders at a faster rate.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ACIES BIO is a biotechnology company that offers Research and Development services to pharmaceutical, chemical, biotech and food industries.
Business Model: unknown
Revenue: 0 - 100000
Employees: 843
Industry: Biopharma
Biomedican is a biotechnology company that conducts research into synthetic biology and cellular agriculture. The company is working on research and development to commercialize its disruptive intellectual property that is focused on emerging industries. Biomedican has marshaled experts across the globe, leaders in their respective fields, to ensure the speed and success of these efforts. Biomedican is based in Berkeley, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
BioIncept is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes and autoimmune diseases.
Business Model: unknown
Revenue: 7.3M
Employees: 25
Industry: Biopharma
Spruce is a California-based biotechnology company that develops and commercializes novel therapies for the treatment of endocrine diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 20
Industry: Biopharma
AM-Pharma develops human alkaline phosphatase therapeutics for the treatment of acute kidney injury.
Business Model: unknown
Revenue: 31.4M
Employees: 30
Industry: Biopharma
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The company’s primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Adynxx is a clinical-stage pharmaceutical company that focuses on developing pain management drugs.
Business Model: unknown
Revenue: 6.7M
Employees: 6
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Statera BioPharma is a biotechnology research agency that provides biotechnology research services. The company was founded in 2014 and is headquartered in Fort Collins, Colorado, United States.
Business Model: unknown
Revenue: 3.7M
Employees: 30
Industry: Biopharma
Valted Seq is a Maryland-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
MetGen manufactures and commercializes tailor-made novel enzymes for packaging, chemicals, water and biogas sectors.
Business Model: unknown
Revenue: 5M
Employees: 30
Industry: Biopharma
Biotechnology in BioPharma, Genetics, Medical Research and Delivery | Integration of AI patented technologies in medicine and biotechnology Engaging in Research and Development in AI, Nanotechnology, Biotechnology, and Biotechnology- Genetics towards the advancement of medicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Quad is a developer and provider of cell separation and activation technology for cell and gene therapy applications.
Business Model: unknown
Revenue: 3M
Employees: 20
Industry: Biopharma
Magalarva processes organic wastes from producers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Novelion Therapeutics is a pharmaceutical company that researches and develops novel drugs for the treatment of inherited retinal diseases.
Business Model: unknown
Revenue: 135.1M
Employees: 109
Industry: Biopharma
Amarillo Biosciences develops low-dose interferon for the treatment of human and animal diseases.
Business Model: unknown
Revenue: 2.5M
Employees: 34
Industry: Biopharma
Ambit Biosciences is engaged in the development of small molecule kinase inhibitors for the treatment of cancer and inflammatory disease.
Business Model: unknown
Revenue: 9M
Employees: 49
Industry: Biopharma
c-LEcta is a Germany-based biotechnology company that develops and commercializes tailored enzymes, microbial strains and biocatalysis for industrial applications.
Business Model: unknown
Revenue: 16.6M
Employees: 83
Industry: Biopharma
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
TherOptix is a provider of novel treatment for anterior and posterior ocular indications. The company seeks to improve treatment outcomes by optimally targeting diseased tissue with effective molecules across a range of indications and molecule classes further leveraging a proprietary, minimally invasive anterior delivery platform.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy&s;s effectiveness. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. NewStem&s;s technology can predict patients&s; resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Nextbiotix is a biopharmaceutical company that develops microbial therapies using breakthrough translational approach to prevent and treat diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Vidac Pharma develops medicines to help people suffering from oncologic and dermatologic medical conditions.
Business Model: unknown
Revenue: 5.7M
Employees: 28
Industry: Biopharma
Sevion is a biotechnology company that engages in the discovery, development and commercialization of therapeutics for cancer and immunological diseases.
Business Model: unknown
Revenue: 150k
Employees: 13
Industry: Biopharma
InDex is a Sweden-based pharmaceutical company that develops and commercializes therapies for the treatment of immunological diseases.
Business Model: unknown
Revenue: 1.4M
Employees: 7
Industry: Biopharma
Endonovo is a California-based biotechnology company that develops and commercializes electroceutical therapies for the treatment of cardiovascular diseases.
Business Model: unknown
Revenue: 14.2k
Employees: 1
Industry: Biopharma
Xentria is an innovative bio-pharmaceutics company whose primary focus is to build an expansive product pipeline of cost-effective and efficacious therapeutics to address critical unmet need for patients suffering from rare diseases, immunologic disorders and oncological conditions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
BioNex provides laboratory automation, liquid handling and OEM solutions to pharmaceutical, agricultural, biotech and diagnostic industries.
Business Model: unknown
Revenue: 2.5M
Employees: 77
Industry: Biopharma
Aptimmune Biologics researches and develops mucosal vaccines for the treatment and prevention of viral diseases in swine.
Business Model: unknown
Revenue: 17M
Employees: 20
Industry: Biopharma
Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications.
Business Model: unknown
Revenue: 17.9M
Employees: 16
Industry: Biopharma
MSDC develops and commercializes novel therapeutics for the treatment of metabolic diseases and mitochondrial dysfunction.
Business Model: unknown
Revenue: 6M
Employees: 25
Industry: Biopharma
TRIANA Biomedicines is a Massachusetts-based biopharmaceutical company that discovers and develops novel small molecule drugs to treat diseases.
Business Model: unknown
Revenue: 1M
Employees: 10
Industry: Biopharma
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders. With or without inhibitors, its flagship program, GENV-HEM, is the first universal gene therapy treatment for hemophilias A and B. The National Hemophilia Foundation has written a letter of support for GENV-HEM and the FDA has designated it as an orphan drug. A further gene therapy is being developed by GeneVentiv for Hemophilia Arthropathy, a degenerative joint disease that affects about 50% of hemophilia patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Virex is a Massachusetts-based biotechnology company that develops and commercializes at-home diagnostic testing kits for homes, workplaces, schools and public spaces.
Business Model: unknown
Revenue: 1.2M
Employees: 14
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Arch Biopartners is a biotechnology firm that focuses on the treatment of respiratory Pseudomonas aeruginosin infections.
Business Model: unknown
Revenue: 37.6k
Employees: 24
Industry: Biopharma
Kantum is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. This targeted therapy will be supported by development of a novel diagnostic test for AKI. Kantum Bio is developing two programs in parallel: (1) Selective receptor antagonist-based therapeutics for AKI and (2) a UDP-G diagnostic test. Kantum’s lead therapeutic development candidate, KB-1801, will be developed for the prophylaxis and treatment of AKI secondary to cardiovascular intervention. Furthermore, KB-1801 has potential in cardiovascular accidents and other conditions associated with AKI in the ICU (e.g. sepsis, polytrauma, nephrotoxicity). The UDP-G diagnostic test will enable early diagnosis of patients at risk for AKI and may be leveraged to select patients and guide their treatment in clinical studies and, ultimately, in clinical practice.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Hygea is a biotech company that develops and commercializes cryotherapy system for the treatment of tumors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
ABM is a pharmaceutical firm that researches, develops, and commercializes therapies for the treatment of brain cancers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
ITabMed is a clinical-stage biotech company located in Shanghai, China. The company was founded in 2020 and is registered in Lin Gang Sci-Tech City, Shanghai. It was a spin-off entity from the former “Generon BioMed Ltd.”. The company is focused on immunotherapy drug research and development to treat cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Kymab is a biotechnology firm that develops and commercializes human antibody-based therapeutics for the treatment of infectious diseases.
Business Model: unknown
Revenue: 195.7M
Employees: 1.4k
Industry: Biopharma
Audion Therapeutics provides development and commercialization of drugs and delivery technologies
Business Model: unknown
Revenue: 3M
Employees: 15
Industry: Biopharma
Tychon Bioscience discovers and develops prosthetic antigen receptors for oncolytic immunotherapy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Jalon Therapeutics&s; goal is to create novel therapies that inhibit vital tumor signaling pathways that are currently untargeted. Our mission is to create medicines that will improve the lives of cancer patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
1983 Osaka University Graduate School of Pharmaceutical Sciences Doctor&s;s Course Completed 1983 Joined Fujisawa Pharmaceutical Co., Ltd. 1998 Senior Researcher, Biological Science Exploration Institute 2005 April AstellasPharma Co., Ltd. (current), Director, PJ Money, Inc., PJ Money Co., Ltd.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze-drying process step unit operations in a continuous production line with the constant infeed of products and the concomitant outfeed of the dried product. Its manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-market, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Cell Care develops regenerative immunotherapeutic elements such as proteins, exosomes and microRNAs for retinal diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ABC Transfer develops and manufactures Rapid Transfer Systems for the biopharmaceutical industry.
Business Model: unknown
Revenue: 500k
Employees: 10
Industry: Biopharma
Aerial biopharmaceutical company that engages in drug development for central nervous system.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its proprietary approach has demonstrated superiority for bone reformation over existing standards of care in various preclinical models. Ankasa Regenerative Therapeutics was established in 2014 and is headquartered in La Jolla, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Biopharma
Synvivia makes ON-OFF switches for genetically engineered organisms. These protein switches are controlled by small molecules. By installing these switches into an organism, Synvivia creates engineered organisms that can be controlled with small molecules.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics. The company licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera was founded in 2015 and is headquartered in Woburn, MA.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Agile is a biopharmaceutical company that engages in developing treatment of antibiotic-resistant therapies.
Business Model: unknown
Revenue: 10.3M
Employees: 39
Industry: Biopharma
Armetheon develops novel anticoagulant with superior safety profile.
Business Model: unknown
Revenue: 2.6M
Employees: 59
Industry: Biopharma
Plato BioPharma is a world-class preclinical drug discovery CRO specializing in vivo physiological and pharmacological studies with complementary biochemical, biomarker and histology analysis in the cardiovascular, renal, pulmonary, diabetes, and hepatic therapeutic areas.
Business Model: unknown
Revenue: 53.3M
Employees: 170
Industry: Biopharma
Emergo Therapeutics is a bio pharmaceutical company that develops drugs to cure infectious diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Advanced BioDesign is a clinical-stage biotechnology company that develops and markets novel anticancer drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Akashi Therapeutics is a biopharmaceutical company develop treatments for Duchenne muscular dystrophy and other rare pediatric diseases.
Business Model: unknown
Revenue: 3.5M
Employees: 40
Industry: Biopharma
Stem Cell Therapeutics (SCT) is a biopharmaceutical company engaged in advancing cancer stem cell discoveries into cancer therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Neuropore is a California-based biopharmaceutical company that develops novel therapeutics for the treatment of neurodegenerative disorders.
Business Model: unknown
Revenue: 4.1M
Employees: 25
Industry: Biopharma
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein
Business Model: unknown
Revenue: 27.7M
Employees: 67
Industry: Biopharma
Cantex develops and commercializes proprietary pharmaceuticals for the treatment of cancer.
Business Model: unknown
Revenue: 11.4M
Employees: 41
Industry: Biopharma
Avalyn is a Washington-based biopharmaceutical company that researches and develops therapies for the treatment of pulmonary fibrosis and respiratory diseases.
Business Model: unknown
Revenue: 4M
Employees: 30
Industry: Biopharma
PhoreMost is a United Kingdom-based biopharmaceutical company that develops phenotypic screening platform and antibody-based therapies to treat infectious diseases.
Business Model: unknown
Revenue: 1M
Employees: 23
Industry: Biopharma
Zezheng Bio is a pharmaceutical R&a;D firm that provides a drug delivery system for improved children&s;s and generic drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Sophiris Bio Inc. (NASDAQ: SPHS) is a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), which it believes is an unsatisfied patient population with significant market potential. Sophiris is currently developing PRX302 for the treatment of BPH symptoms which is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. PRX302 is currently in Phase 3 clinical development with a blinded interim analysis expected in the second half of 2014 followed by a complete data analysis in the second half of 2015. For more information, please visit www.sophiris.com.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Qiagen develops a molecular diagnostics platform that offers genome sequencing and biomarker validation for targeted oncology and immunotherapy.
Business Model: unknown
Revenue: 4.5M
Employees: 55
Industry: Biopharma
Molcure is antibody and Peptide drug-focused biopharmaceutical company whose passionate associates are dedicated to improving the lives of patients by developing and providing more effective therapeutics and supportive care products. Molcure represents high quality antibody and target discovery. With cutting edge technology in-house, Molcure is the partner of choice for therapeutic antibody discovery. At Molcure they combine a deep knowledge of NGS, bioinformatics and antibody biology with automated discovery system. The antibody discovery platform Abtracer delivers superior functional antibodies. Their technology is validated through a number of partnerships. They are seeking new partnership opportunities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Ampersand Health is an investment firm that focuses on healthcare organization.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Materiomics BV is a biotech company located in Enschede, The Netherlands. The company has developed TopoChip. Materiomics BV designs and identifies the best surface for improved functionality and durability of medical and cell culture devices.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Wellesley Pharmaceuticals ensures that the ability of Nocturol to reduce and sometimes eliminate nocturia symptoms can be disseminated. Wellesley Pharmaceuticals is in the development of an innovative, patented drug for treating Nocturia (frequent urination at night). Currently, there are no drugs on the market focused on nocturia and Wellesley plans to be first to market in the space. They believe that their proprietary drug, Paxerol, positions them to be the industry leader, addressing a massive unmet clinical need. Paxerol offers a significant advancement in terms of mechanism of action relative to existing indirect treatments of nocturia and should allow them to provide relief to hundreds of millions of people.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients. It develops an anticoagulant for critically ill patients in the ICU who experience kidney failure and need to go on an artificial kidney machine called continuous renal replacement therapy (CRRT), which is 24/7 dialysis. This machine involves circulating blood outside the patient through a filter. Eventually, blood will clot in the filter unless it is anticoagulated. When the filter clogs, doctors and nurses must stop the machine to change it – throwing away clotted blood and in the process, increasing blood loss and the need for transfusions.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Henlez uses precise enzymes to create disruptive topical treatments for recurrent follicular skin problems. The company can be reached via mail, phone, or physical address.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Cytodel is a biopharmaceutical company that provides Cyto-111 and Cyto-012 products for nervous system disorder and neurodegenerative diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Regulonix develops and commercializes non-opioid therapeutics for the treatment of chronic pain.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Fuse Medical is a Texas-based medical device company that designs and distributes products including cannulated screws and cotton wedges for the healthcare sector.
Business Model: unknown
Revenue: 18.1M
Employees: 70
Industry: Biopharma
Exochain develops general legal and cyber liability risk-reducing tokenized blockchain protocols that deliver secure ownership, custody, and care of mission-critical identifying data. Its patent pending Odentity scores unique identifiers such as network, browser, client, biometry, and demonstrated knowledge weighted by the legal jurisdiction of parties&s; within differing geographies and corpora of law. Exochain API methods are called during login processes and elsewhere to reduce risks by establishing and recording the identity and ownership of data elements. The LYNK Protocol provides a mechanism to ensure permission-based tokenized access to data elements governed by legal terms and conditions for both blockchain smartER-contracts and any overarching governing business terms and conditions, reps, warranties, and restrictions. The signed, sealed, fingerprinted, data processing governance contracts are then recorded to provide evidentiary-quality compliance and enforceability.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Protein Dynamic Solutions develops a novel throughput platform for screening protein therapeutics of the patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Ennovabio focuses on the research and development of drugs for diabetes complications, tumors and immune inflammations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 24
Industry: Biopharma
Sirakoss is a medical device company that develops and markets nano synthetic bone graft substitutes for spine and trauma bone grafting procedures.
Business Model: unknown
Revenue: 2M
Employees: 4
Industry: Biopharma
Siamab is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 3M
Employees: 10
Industry: Biopharma
BioReperia is located at Linköpings University. Their researchers have more than 10 years experience developing and using zebrafish models for medical research including toxicology and tumor biology. Their models are today widely used in both academic and industrial research and drug development projects around the globe.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ULURU engaged in developing wound care and muco-adhesive film products.
Business Model: unknown
Revenue: 5.5M
Employees: 2
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Veridicus Health provides clinical care management, medication therapy management and pharmacy benefit manager services.
Business Model: unknown
Revenue: 5M
Employees: 130
Industry: Biopharma
Cardax develops nutraceutical and pharmaceutical products.
Business Model: unknown
Revenue: 500.7k
Employees: 10
Industry: Biopharma
Somru Bioscience is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research, diagnostic and therapeutic applications
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ELDICO Scientific is a Switzerland-based developer, manufacturer, and distributor of electron diffractometers for the pharmaceutical and agrochemical industries.
Business Model: unknown
Revenue: 1.5M
Employees: 8
Industry: Biopharma
GeneQuine develops novel therapies for degenerative joint diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Pleryon is a drug delivery platform company dedicated to improving the standard of living across the global community by developing programs utilizing advanced drug delivery technologies. Pleryon&s;s platform is supported by pillar technologies and covers a broad spectrum of molecules and therapeutic areas.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
C4Diagnostics develops and commercializes IVD kits based on its proprietary, versatile, phenotypic and simple technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
DTCO (Digital Treasury Corporation) was founded in 2014. The corporate management team consists of international blockchain scientists along with elite members from the fields of finance, ICT, and biopharma industries. DTCO serves as a bridge between business and blockchain for wide range of applications including IP, healthcare, supply chain and green energy. Through industry collaborations, we are confident blockchain technology can bring great value to society.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
We innovate for our future
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Micro Rock Medical is a biopharma and medical firm that focuses on precise molecular diagnosis for infections.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Check-Cap is a medical diagnostics company that researches and develops capsule-based systems for preparation-free colorectal cancer screening.
Business Model: unknown
Revenue: 36
Employees: 65
Industry: Biopharma
Dynacyte is a biotech and bioscience informatics company that builds the physical and virtual foundations to invent radical bioprocesses comparable to those that emerged from our untamed planet. Founded in 2021 and is based in Singapore, Central Region, Singapore.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Peptide Logic is a biopharmaceutical company researches and develops peptide-antibody conjugates for pain management.
Business Model: unknown
Revenue: 0 - 100000
Employees: 7
Industry: Biopharma
Covis Pharma is a distributor of pharmaceutical drugs for the treatment of cardiovascular and central nervous system diseases.
Business Model: unknown
Revenue: 57M
Employees: 90
Industry: Biopharma
Sorbent develops therapies for cardiovascular and renal diseases.
Business Model: unknown
Revenue: 5M
Employees: 108
Industry: Biopharma
BeneVir&s;s immunotherapies for cancer are designed to induce the immune system to rid the body of two types of tumor cells: those currently responsible for cancer and those responsible for tumor recurrence and poor clinical outcomes. This is a unique approach in the emerging field of cancer immunotherapy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Telik, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
BioCurity is a biotechnology company that develops nanoparticle drug to protect and treat healthy tissue from damages of radiation thearpy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors. The company&s;s encapsulated anti-cancer agent is developed using a novel formulation of a particular halopyruvate called 3-bromopyruvate to target cancer by directly attacking one of its key hallmarks, tumor glycolysis, enabling medical practitioners to achieve efficacy as an anti-cancer agent with a controlled and mild toxicity profile. Cage Pharma was founded in 2017 and is headquartered in Baltimore, Maryland.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
CGeneTech manufactures and sells synthetic DNA purification kits for research and medicinal applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications. It aims to improve the penetration of agents across the skin barrier for common and visible skin conditions. It develops proprietary topical aesthetic and therapeutic prescription-strength skin care systems to isolate pure and potent MSC-derived Exosomes, enabling healthcare institutions to solve the unmet needs of skincare aging. The company was founded in 2019 and is based in San Jose, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Bioheng is a Jiangsu-based clinical-stage biopharmaceutical company that develops and commercializes cell and gene therapies for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 60
Industry: Biopharma
LXP Group develops LX-Process. The LX-Process cracks 2G biomass and can readily be adapted for large-scale 2G ethanol manufacturing but is also inversely scalable, enabling economic retrofit of smaller, decentralized biogas plants. Also, the LX-Process eliminates a principle hurdle faced in bio-processing, namely the presence / concentration of inhibitors, which are formed in all existing 2G pre-treatment methods.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Tts Pharma develops and commercializes cannabinoid products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Bioarray develops and commercializes breast cancer predictive molecular tests for the optimization of drug discovery and development.
Business Model: unknown
Revenue: 5M
Employees: 51
Industry: Biopharma
Kankyo Daizen is a biotechnology company.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
BTG focuses on developing and commercializing of pharma products for cancer, vascular and emphysema diseases.
Business Model: unknown
Revenue: 870.5M
Employees: 1.5k
Industry: Biopharma
GreenLight Medicines is a biopharmaceutical company that focuses on research and development of cannabinoid molecules from proprietary strains.
Business Model: unknown
Revenue: 3M
Employees: 12
Industry: Biopharma
WeCare is a U.S. &a; European based medical technology startup operating in Africa. Our mission is to democratize healthcare by delivering quality, affordable, and accessible healthcare to the masses. We presently operate 4 clinics in Sub-Saharan Africa with plans to expand into other markets in Africa and Europe. We’ve served over 1.2 million customers to date, including 425 babies delivered and thousands of vaccines administered. We are pointedly working to become the leading provider of healthcare and medical technology services in greater Africa within 3 years. We provide quality, affordable, and accessible care to huge populations that are currently underserved. Our offerings exceed that of the competition in a variety of ways: 1. We maintain low prices in order to reach the most customers possible and maintain the fierce brand loyalty and reputation we’ve earned. 2. Our growth strategy aims to provide all Sub-Saharan Africans access to a clinic in under two hours, and our templated clinic model ensures that customers know what to expect regardless of which location they visit. While other singley owned clinics are a gamble, our service is ubiquitous and reliable. 3. Our specialized clinics offer services not currently available in many locations, such as maternity care or emergency care. 4. Our on-demand services provide care for those unable to reach a clinic, as well as affluent customers who demand specialized attention. These will be expanded to reach more mainstream customers over time. 5. Our technological solutions, including universal medical records, patient analytics, and predictive AI elevate the standard of care to a new level. These features enable us to treat our patients proactively, while the rest of the industry still operates under a reactive model. In addition to these points, our work builds the foundation for a thriving social infrastructure. We bring with us a sizeable need for skilled labor and education. Our presence is already driving significant traffic to the areas where we operate, resulting in local industries flourishing around our clinics. We foresee our work elevating communities, countries, and Africa as a whole by breaking down barriers of health-insecurity and fostering the growth of infrastructures that will unite Africa with the rest of the world.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Business Model: unknown
Revenue: 4M
Employees: 50
Industry: Biopharma
Navid Biotech is a biotech firm that focuses on the R&a;D of simple and visual new nucleic acid detection technology.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
ŌGI Bio is a newly formed start-up company from The University of Edinburgh with the mission to revolutionize the way that microbes are grown and managed.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
INF is a China-based biopharmaceutical company that develops and commercializes cell and gene therapies for the treatment of human diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Phenex develops novel proprietary small molecule drugs targeting nuclear receptors.
Business Model: unknown
Revenue: 39M
Employees: 69
Industry: Biopharma
Genevide is a biotech company that specializes in gene research and development. Genevide was founded in 2019 and is located in Suzhou, Jiangsu, China.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Maxwellia is a UK-based self-care company that provides prescription-only medicines from the local pharmacy.
Business Model: unknown
Revenue: 0 - 100000
Employees: 2
Industry: Biopharma
IXALTIS engages in developing proprietary therapeutics to treat genitourinary disorders with unsatisfied medical need.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
FortuneRock (China) Ltd., a privately held biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 wholly owned subsidiaries, Tianjin SinoBiotech Ltd., SinoBiotech (Tianjin) Ltd. and Beijing Bio-Fortune Ltd., the group is focused on the discovery, development, and commercialization of novel, patent-protected gene-based recombinant protein drugs with high clinical value for the treatment of life-threatening and debilitating diseases. Currently, the company has one drug in clinical Phase I, one in clinical Phase II, another waiting for approval to enter into clinical Phase I, and several novel drugs in pre-clinical studies, all for different indications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Cytocybernetics specializes in cellular electrophysiology. They developed the Cybercyte, which is a very powerful, but user friendly, plug and play dynamic clamp system. They offer a complete range of CRO services, including FDA mandated drug safety screening, custom electrophysiology, custom modelling, and custom analysis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
NeXeption is a biopharmaceutical management company that brings together product opportunities, management expertise, and funding for partnerships.
Business Model: unknown
Revenue: 18.8M
Employees: 85
Industry: Biopharma
Xymonic Pharma is a biopharmaceutical company that engages in developing and commercializing oncology drug products.
Business Model: unknown
Revenue: 0 - 100000
Employees: 27
Industry: Biopharma
Telormedix SA, a biopharmaceutical company, develops immune-selective drugs for the treatment of cancer and autoimmune diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Paragen Bio is a pharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases.
Business Model: unknown
Revenue: 1M
Employees: 21
Industry: Biopharma
NuVessl is a nanotechnology company that specializes in pharmaceutical, product development, and research development. NuVessl is a world leader in nano-encapsulation delivery systems enabling the delivery of ingredients faster, stronger and more effectively to the body. NuVessl&s;s delivery systems are all- natural, patent protected and in expensive. The company was founded in 2017 and is headquartered in Alberta, Canada.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
BIOGELX engages in developing cell matched hydrogels for three dimensional cell culture based on patented peptide technology.
Business Model: unknown
Revenue: 2.6M
Employees: 37
Industry: Biopharma
AesculaTech believes in building better lives through smart chemistry. Our vision: a product ecosystem that responds to our bodies and our environment, driven by materials with a mind of their own. Leveraging a proprietary material platform and a team of talented engineers, we build custom molecules to meet mechanical, safety, or stimuli-responsive criteria. Founded in 2016, we originally applied these materials to sustained ocular drug delivery, but the technology has taken on a life of its own in a pipeline that ranges from biomedical to consumer products. Humidifeye, our patient-adaptable treatment for Dry Eye Disease, will be the first of many best-in-class therapies. Offering improved comfort and safety in form that drastically cuts clinic time, Humidifeye brings an innovative solution to a market expected to surpass $5 Billion by 2024 with a CAGR of 6.5%. This will be the first of many breakthrough technologies. Led by Niki Bayat, one of MIT TR’s 35 innovators under 35, AesculaTech has grown from a founding pair of USC Chemical Engineers into a dedicated team with experience in medical devices, organic chemistry, pharmaceuticals, industrial materials, medicine, and other advanced fields. As graduates of renowned accelerators YCombinator and TMCx, our work is also guided by a powerhouse cast of advisors in chemical engineering, medicine, and entrepreneurship. They have already created successful companies, saved lives, and changed the world. With their help, we will do the same.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
SkinBioTherapeutics is a life science company that focuses on skin health specializes in cosmetics, infection control and eczema healthcare sectors.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Health Vector is a health and wellness company that provides information regarding healthier lifestyles.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Life Magnetics is commercializing a graphene based magnetic bead for RNA diagnostics, theraputics, and research.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Paranta Biosciences develops novel biotherapeutics based on recombinant human follistatin to treat conditions involving inflammation and fibrosis.
Business Model: unknown
Revenue: 29.4M
Employees: 423
Industry: Biopharma
Toralgen is a biopharmaceutical company that develops novel therapeutics for diabetes and pancreatitis.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
CureTech Ltd. is a biotechnology company developing novel, broad-spectrum, immune modulating products for the treatment and control of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Shanghai Huaota Biopharm is a wholly owned subsidiary of Huahai Pharmaceuticals and was established in September 2013. Huaota is dedicated to develop high quality biological drugs for global market to meet the demand of availability and affordability for high-end biological products from global patients. Huaota employs the state-of-the-art biopharmaceutical manufacturing technology and equipments to build production line meeting the GMP requirement from CFDA, US FDA and EU EMA. Huaota currently has one 200L and one 1000L disposable bioreactor and two fill-and-finish lines to support both prefilled syringe and vial filling.
Business Model: unknown
Revenue: 0 - 100000
Employees: 201 - 500
Industry: Biopharma
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Mecwins develops a nanotechnological platform that characterizes mechanical based sensor devices such as cantilevers, bridges and membranes.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
to‑BBB develops treatments for brain disorders.
Business Model: unknown
Revenue: 9.9M
Employees: 55
Industry: Biopharma
Aggamin is an early-stage biotechnology company founded in early 2010 to develop and commercialize therapies for a variety of vascular diseases. The lead program is focused on preeclampsia — a currently untreatable disease affecting 5% of pregnancies with an annual cost to the U.S health care system of $10 billion. Lead product is an extracorporeal device for preeclampsia that reduces circulating pathogenic proteins to improve maternal and fetal health. The company objectives are to manufacture and commercialize the preeclampsia device as a safe first-in-class treatment for preeclampsia that will control maternal symptoms and extend pregnancy, thus improving both maternal and neonatal outcomes.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Sanarx is a pharmaceutical company that researches, develops and commercializes drugs for the treatment of orphan diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. It was established in April 2020 and is initiated by the team of Professor Yin Hang, School of Pharmacy, Tsinghua University.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ZeClinics is a Start-up biotech offering an outsourcing solution for safety and efficacy screenings of novel chemical molecules using zebrafish.
Business Model: unknown
Revenue: 2M
Employees: 37
Industry: Biopharma
Xinji Pharmaceuticals is mainly engaged in the R&a;D of new drug preparations and drug release systems. The company is especially involved in the application and promotion of drug-controlled release, sustained release, and targeted drug release technologies in the industrialization of biomedicine.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Parexel is a Massachusetts-based clinical research organization that provides solutions such as consulting and medical communications for the pharma and biotech industries.
Business Model: unknown
Revenue: 2.5B
Employees: 18k
Industry: Biopharma
Anterios develops and distributes botulinum toxin-based prescription products for the healthcare sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Biopharma
HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company was founded in 1992 by four experienced research scientists to provide sophisticated research and development support services on a contract basis to the biotechnology industry.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Jenrin Discovery, is a pharmaceutical company, focuses on developing therapeutics for a variety of chronic diseases. It develops therapeutics for various diseases, including obesity, diabetes, and autoimmune/inflammatory disorders.
Business Model: unknown
Revenue: 25.6M
Employees: 69
Industry: Biopharma
AmericanPharma Technologies provides technology for the monitoring of critical healthcare and biopharmaceutical environments. AmericanPharma specializes in offering to support the compliance needs of companies that make, use, or store pharmaceuticals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Covagen develops protein-based therapeutics for the treatment of inflammatory diseases and cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 108
Industry: Biopharma
Lianchuang Bio is a pharmaceutical company. They offer R&a;D, production, and marketing of advanced pharmaceutical intermediates. They specialize in the organic synthesis and enzymatic synthesis of pharmaceutical products. They provides product line with target diabetes drugs as core products and other products as supplements.
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Fedora Pharma discovers and develops antibiotic products for life-threatening microbial drug resistance.
Business Model: unknown
Revenue: 3.6M
Employees: 74
Industry: Biopharma
CCB is the first cannabis company incubator in Latam. We partner with talented entrepreneurs to conceive, launch, and scale new cannabis businesses. by surrounding the startups with world-class expertise from our executive team, we compress the amount of time it takes for a cannabis startup to move from an idea to a viable business. We select startups and we help them reach their true potential.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Rodos Biotarget develops and commercializes nanocarrier based drugs for the treatment of cancer, chronic infections and neurological disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Marinomed develops novel therapies to treat respiratory and ophthalmological diseases.
Business Model: unknown
Revenue: 5.7M
Employees: 27
Industry: Biopharma
Vitality Biopharma is a California-based biotechnological company that develops treatments to treat neurological and inflammatory disorders.
Business Model: unknown
Revenue: 258.3k
Employees: 3
Industry: Biopharma
Cadrenal is a Florida-based clinical-stage biopharmaceutical firm that focuses on the research and development of novel therapies for the treatment of renal diseases and AFib.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
I.C. Medical manufacturers laser &a; electrosurgery products for surgical smoke evacuation.
Business Model: unknown
Revenue: 6M
Employees: 82
Industry: Biopharma
OnCore Biopharma develops all-Oral cure for patients suffering from chronoic Hepatitis B infection.
Business Model: unknown
Revenue: 11.6M
Employees: 45
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
PPD is a global contract research organization (CRO) providing discovery, development, and post-approval services as well as compound partnering programs. Their clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. PPD applies innovative technologies, therapeutic expertise, and a firm commitment to quality to help customers bend the cost and time curve of drug development to provide life-changing therapies that improve health.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals. It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively. Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
The SuperX team is engaged in the discovery of antibodies against an undisclosed target in the blood coagulation cascade. SuperX hopes to reach the clinic in 2019.A preclinical stage biopharmaceutical company, based at Babraham Research Campus, developing novel anticoagulant drugs
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Causeway Therapeutics is a developer of therapies for tendon injuries and disorders.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Odyssey Thera, a biopharmaceutical company, develops cellular pharmacology strategy for the identification of medicines for human diseases.
Business Model: unknown
Revenue: 13.4M
Employees: 52
Industry: Biopharma
Stem Pharm was founded in 2015 with the purpose of being a trusted supplier of synthetic biomaterials that are specifically designed to meet customer&s;s requirements as they develop more advanced cellular models for drug discovery and toxicity screening and cellular therapies for regenerative medicine applications. Stem Pharm is located in the Fitchburg Technology Campus, near the University of Wisconsin campus. It Leverages its expertise in biomaterials and cellular interactions to develop high-value applications of organoids (3-D in vitro models) for drug discovery and cell-friendly coatings for the manufacture of-cell based therapies.
Business Model: unknown
Revenue: 8.5M
Employees: 33
Industry: Biopharma
Vortex Surgical designs, manufactures and distributes surgical products and systems for vitreo retinal surgery.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
iReprogram is a cell regeneration lab that aims to expedite the delivery of next-generation personalized medicine. The company was founded in 2017 and is headquartered in Ann Arbor, Michigan.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
NsGene is a Danish Biotech company located in the Medicon Valley region. The Company is committed to developing novel biological products for the treatment of neurological diseases and is focusing on multiple indications with high unmet needs, including Alzheimer&s;s disease, epilepsy, neuropathic pain and Parkinson&s;s disease.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
VetDC is a pet biopharmaceutical company that develops anticancer therapies for animals.
Business Model: unknown
Revenue: 5M
Employees: 28
Industry: Biopharma
Proteios is a Washington-based biotechnology company that develops and commercializes advanced therapy medicinal products for the healthcare industry.
Business Model: unknown
Revenue: 4.1M
Employees: 20
Industry: Biopharma
Halodine is a biotechnology company that develops and markets povidone-iodine antiseptics for nasal and oral applications.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Inspira Pharmaceuticals conducts research and development on treating respiratory diseases. It aims to create technology for therapy and medicines for prevention. Inspira Pharmeceuticals was founded in 2020 and is located in London.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of their priorities. IDP Pharma&s;s efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, the company has built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Corevitas is a Massachusetts based company that provides safety, patient engagement and community services.
Business Model: unknown
Revenue: 156.1M
Employees: 567
Industry: Biopharma
RheoDx is a Spain-based company that develops and sells micro-rheometry devices for monitors red blood cell conditions.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Biopharma
BiovelocITA provides consulting and mentorship services for biotechnology companies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biowater Technology designs and engineers next generation technologies and solutions for the municipal and industrial wastewater treatment markets. The team has experience from over 300 projects and installations of MBBR worldwide. The company provides innovative technologies and solutions for biological treatment of water and wastewater. Products include but are not limited to: MBBR, IFAS and Package Plants. Biowater has offices in the United States and Norway with partners and representatives around the world
Business Model: unknown
Revenue: 5.6M
Employees: 13
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Ferrer is a fully vertically integrated pharmaceutical firm from research and development, through manufacturing, to sales and distribution.
Business Model: unknown
Revenue: 257.2M
Employees: 3.2k
Industry: Biopharma
Lanzhou Baiyuan Gene Technology consists of a group of biomedical professionals. It has been committed to the research of the combination of traditional medicine and modern high technology, and to the research of medical and pharmaceutical functional genomics. with the development of biochips and molecular diagnostics as its core business.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Kansas is a global healthcare company specialized in medical devices, diagnostic solutions, nutrition, and branded generic pharmaceuticals businesses. Our medical and diagnostic equipment products are widely used around the world by hospitals, laboratories, blood banks, and healthcare centres to diagnose and monitor diseases. Connect with us at www.kansaslaboratories.com and on Instagram @kansaslaboratories 堪萨斯州是一家全球性医疗保健公司,专门从事医疗设备,诊断解决方案,营养和品牌仿制药业务。 我们的医疗和诊断设备产品在全球范围内被医院,实验室,血库和医疗中心广泛用于诊断和监测疾病。 通过www.kansaslaboratories.com和Instagram @kansaslaboratories与我们联系
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin. The company&s;s drugs are focused on wound care, pain management and itch management, enabling patients treatment of mutation causing dystrophic epidermolysis bullosa.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Spinnaker Biosciences specializes in offering ophthalmic drug delivery technologies. The company was incorporated in 2009 and is based in Solana Beach, California.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Biopharma
Discovery Life Sciences is an Alabama-based company that provides services such as biospecimen analysis and procurement for the pharmaceutical industry.
Business Model: unknown
Revenue: 200M
Employees: 450
Industry: Biopharma
InFlectis BioScience is leveraging its leading expertise in the cellular defense system against misfolded proteins and drug discovery to identify and develop small molecules which modulate key proteins involved in misfolded protein disorders. Endoplasmic Reticulum (ER) proteostasis is vital for cellular function and cell survival. Many different perturbations can alter the folding capacity of the ER and may cause accumulation of unfolded or misfolded proteins inside the ER, a cellular condition referred to as ER stress. To safeguard proteostasis, the mammalian ER has a complex machinery to maintain the integrity of cells. This adaptive programme is called the unfolded protein response (UPR).
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Glauconix is a biopharmaceutical firm that researches and develops ophthalmology based drugs.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
They are engineering tools and services to combat one of the most costly and emotionally damaging issues in healthcare, opioid addiction.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
AVX Pharma is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for dry eye syndrome.
Business Model: unknown
Revenue: 13M
Employees: 10
Industry: Biopharma
retail cannabis distributor and full-service certified organic cannabis extraction and formulation lab. They source certified organic CBG hemp from farmers to create CBG crude and distillate.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Clovis Oncology provides oral molecule drugs that focuses on acquiring, developing and commercializing cancer treatments.
Business Model: unknown
Revenue: 133M
Employees: 410
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&a;D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&a;D market operation team at home and abroad.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
Sonoran Biosciences is a preclinical-stage pharmaceutical company that develops antibacterial gel for the treatment of surgical site infection.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Curtana Pharmaceuticals is a developer of molecule therapeutics for the treatment of glioblastoma and brain cancers.
Business Model: unknown
Revenue: 1.5M
Employees: 12
Industry: Biopharma
BaroFold provides protein refolding, aggregate characterization, formulation studies and microbial expression services.
Business Model: unknown
Revenue: 8M
Employees: 40
Industry: Biopharma
Sensorygen focuses on using computational neurobiology to discover naturally occurring compounds that alter smell and taste perception.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Deep Science Ventures is an accelerator that works with scientists to build companies, from scratch, across domains from biochemistry to nano-tech. They provide a basic salary to fund the first 3 months of the program, followed by a £30k investment into those teams that demonstrate the commercial and technical viability of their startup. It is based in London, United Kingdom.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Pamlico BioPharma develops human monoclonal antibodies for the diagnosis and treatment of infectious and cancer diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Corline Biomedical is a pharmaceutical company based in Sweden. The company develops, manufactures, and markets heparin based solutions to improve kidney transplantation, cell therapies and applications in the evolving field of regenerative medicine. Corline was founded in 1991.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Laboratoire PhytoChemia is the trusted partner you are looking for to guarantee the quality of all your products containing vegetal ingredients. We are specialized in standardization and chemical quality control of natural products with medicinal, cosmetic and alimentary properties.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
We&s;re convinced that psychiatry needs a new way in which things are done. It&s;s a branch of medicine that is far behind the other ones. That is why in Sigmind we are revolutionizing clinical psychiatry through the development of the first “laboratory analysis of the mind”. We believe that people&s;s speech is the window to their mental health. Therefore, with our algorithms we are helping psychiatrists to improve the accuracy and efficiency of mental disorders diagnosis, treatment, and follow-up with an intuitive, quantitative and objective Artificial Intelligence-based toolbox that calculates metrics from patient&s;s speech. On the other hand, we seek to pave the way for precision medicine in psychiatry. Our Machine Learning classifier, boosting by NLP, helps improve the accuracy of a new drug or treatment in new patients with mental disorders. It consists of custom modules to assess a patient&s;s likelihood to respond to different pharmacotherapies. It represents an increase in the probability of achieving satisfactory results saving about 20% of R&a;D costs and reduce the risks for patients in clinical trials.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Medbotics is a Canada-based health systems company that develops magnetic resonance imaging diagnostic and therapeutic approaches to treat cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Carlina Technologies is a biotechnology company based in Angers that specializes in the development of micro and nanomedicines using innovative encapsulation processes of small molecules and therapeutic proteins. Carlina, born of the rapprochement between Professor Jean-Pierre Benoit, director of the unit INSERM 1066 (laboratory of Micro and Nanomedecines Biomimetics), and of Olivier Meyer, doctor in Pharmaceutical Sciences of the University of Paris XI, is laureate 2010 national competition to help start up innovative technologies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Elementa Labs provides voice assistants for biomedical lab workers.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major disease areas. The Company was founded by a team of professionals that combine extensive experience in business administration, clinical research, pharmaceutical product development, as well as company and patent law.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
KBI is a North Carolina-based contract development organization that provides services such as cell line development and clinical support for the pharmaceutical sector.
Business Model: unknown
Revenue: 125M
Employees: 1.3k
Industry: Biopharma
Translational Research Management (TRM) is a management services organization committed to building a nationwide network of community based medical oncology professionals dedicated to offering research studies to their patients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
LiVeritas Biosciences is a hybrid life science data and analytics company solving the problem of mass spectrometry implementation in the world of drug development. We utilize transformative solutions that unify drug development knowledge, data, insights, and strategy. As a result, we are empowering our clients to harness the power of molecular integrity for early informed decision-making helping them advance the right candidates early in drug development.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Bakhu is a California-based company that manufactures and distributes cannabis-infused products for industries such as healthcare and food and beverage.
Business Model: unknown
Revenue: 0 - 100000
Employees: 3
Industry: Biopharma
MobiDrop is a China-based molecular diagnostic company that designs and develops barcoding and microfluidic technologies for the healthcare sector.
Business Model: unknown
Revenue: 2.5M
Employees: 100
Industry: Biopharma
Emmaus is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of orphan and sickle cell diseases.
Business Model: unknown
Revenue: 15.5M
Employees: 62
Industry: Biopharma
Navarro offers fragrances, health and beauty care products.
Business Model: unknown
Revenue: 8.8M
Employees: 183
Industry: Biopharma
Genesis Research is a New Jersey-based HEOR organization that offers services such as real-world evidence strategy and value proposition for life sciences companies.
Business Model: unknown
Revenue: 15.1M
Employees: 120
Industry: Biopharma
Ezra Innovations, LLC develops, manufactures, and offers drug delivery technology and equipments. The company was incorporated in 2008 and is based in Little Rock, Arkansas.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
APCER Life Sciences provides pharma covigilance, medical information, medical writing, and regulatory services to pharma & biotech companies across the drug life cycle.
Business Model: unknown
Revenue: 25M
Employees: 750
Industry: Biopharma
Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.
Business Model: unknown
Revenue: 2.4B
Employees: 2.4k
Industry: Biopharma
Shire is a biopharmaceutical company that develops therapeutics for rare diseases and also offers patient advocacy services.
Business Model: unknown
Revenue: 15.2B
Employees: 23k
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees:
Industry: Biopharma
Vitrotem offers an easy-to-use automated system for the fabrication of graphene liquid cells (GLCs). Fabricated on a standard TEM grid, GLCs allow a researcher to record transmission electron microscopy on liquid samples in a conventional TEM system - without the need for vitrification or the use of special sample holders. GLCs enable dynamic TEM imaging of whole biological cells as well as single molecules and nanoparticles in liquid at unprecedented resolution.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
IMS Health is the world&s;s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients&s; day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide.
Business Model: unknown
Revenue: 0 - 100000
Employees: 10001 - 1
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 501 - 1000
Industry: Biopharma
Pipette.com offers brands of pipettes, tips and service.
Business Model: unknown
Revenue: 15M
Employees: 75
Industry: Biopharma
CSL Behring is a Pennsylvania-based biopharmaceutical company that develops protein-based therapies for the treatment of bleeding disorders and pulmonary disease.
Business Model: unknown
Revenue: 10.3B
Employees: 30k
Industry: Biopharma
Jupiter Biomedical Research is a company that offers commercial services.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Gemini manufactures and supplies cell culture sera and biological reagents for academic research, biotechnology and pharmaceutical companies.
Business Model: unknown
Revenue: 2.3M
Employees: 33
Industry: Biopharma
Piper Therapeutics is focused on order pathways that govern immune and inflammatory response.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Chr. Hansen is a Denmark-based bioscience firm that develops and supplies products such as enzymes and probiotics for sectors including pharmaceutical and food and beverage.
Business Model: unknown
Revenue: 1.2B
Employees: 3.8k
Industry: Biopharma
Emmes is a contract research organization that offers clinical research services for public health and biopharmaceutical innovation. They work side-by-side with leading researchers to tackle challenges that have an impact on public health throughout the world. Emmes was founded in 1977 and is based in Rockville, Maryland.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Biopharma
Coquí Pharma manufactures medical diagnostic and therapeutic radioisotopes.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Genzyme is a pharmaceutical company that develops and commercializes drugs for rare diseases and multiple sclerosis.
Business Model: unknown
Revenue: 1B
Employees: 4.7k
Industry: Biopharma
Rethink Medical is a medical company that aims to develop innovative medical solutions to various health problems. This includes creating new remedies or significantly improving existing ones. The first product is the T-Control Urinary Catheter. It
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
AesRx engages in the development of drugs for the treatment of sickle cell disease.
Business Model: unknown
Revenue: 24.9M
Employees: 64
Industry: Biopharma
KinderPharm is a contract research organization that offers pediatric dose prediction, formulation development and clinical trial services.
Business Model: unknown
Revenue: 1.3M
Employees: 10
Industry: Biopharma
ProAxsis Ltd. specialises in the development of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection and measurement of active protease biomarkers of disease. Its rapid and easy-to-use tests incorporate patented “ProteaseTags®”; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as bronchiectasis, cystic fibrosis and COPD. Its first immunoassay, for the specific measurement of active neutrophil elastase as a biomarker of lung infection and inflammation, was registered with a European CE Mark in 2016.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
At Platome Biotechnology we believe that quality matters from day one. Our mission is to provide high quality solutions for cell culture that are free of animal components and consist only of human growth factors derived from platelets. We provide a platform that allows researchers and companies to be quicker at translating basic research into the clinics by using an environment that mimics the human body from the first experiment onwards.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Hyperion Therapeutics is a bio-pharmaceutical company that develops novel therapeutics to treat for orphan and hepatic disease.
Business Model: unknown
Revenue: 125.3M
Employees: 80
Industry: Biopharma
Mount Tam is a biopharmaceutical company that researches and develops mTOR inhibitors for treating autoimmune diseases.
Business Model: unknown
Revenue: 546
Employees: 2
Industry: Biopharma
TRICCAR Holdings is a bioceutical company that develops and commercializes treatments for cancer and hypothyroidism.
Business Model: unknown
Revenue: 98.4k
Employees: 1 - 10
Industry: Biopharma
Pharmascience is a Canada-based pharmaceutical company that develops and commercializes generic drugs and over-the-counter products for the healthcare industry.
Business Model: unknown
Revenue: 585M
Employees: 1.5k
Industry: Biopharma
Trestle Biotherapeutics is a biotechnology company that introduces bioengineered kidneys for patients with kidney disease. The company&s;s services allow healthcare providers to reduce their reliance on dialysis while also enhancing the disease status of renal patients through the combination of stem cell biology and bio-fabrication. Trestle Biotherapeutics was founded in 2020 by Alice Chen and Ben Shepherd and is based in San Diego, California, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling. It is the mission of ARTPred to make our unique technology available for all IVF patients worldwide in order to avoid unnecessary treatment burden.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Beryllium provides crystallography, membrane proteins and fragment screening services for biotechnology, academic and research organizations.
Business Model: unknown
Revenue: 8.5M
Employees: 96
Industry: Biopharma
Aerium is a Massachusetts-based biopharmaceutical firm that researches and commercializes antibodies and small-molecule antiviral drugs for the treatment of infectious diseases.
Business Model: unknown
Revenue: 1M
Employees: 7
Industry: Biopharma
Allied BioScience is a biotechnology company that develops and commercializes antimicrobial coating products to healthcare facilities.
Business Model: unknown
Revenue: 5.5M
Employees: 47
Industry: Biopharma
Nabi develops preventive measures and treatements. Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
CannapharmaRx is an investment firm that focuses on investing in pharmaceutical research facilities.
Business Model: unknown
Revenue: 0 - 100000
Employees: 4
Industry: Biopharma
Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinical information, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
CMC Biologics is engaged in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and therapeutic proteins.
Business Model: unknown
Revenue: 5M
Employees: 314
Industry: Biopharma
Two Labs is a consulting company that offers post-launch commercialization, pricing strategy and market intelligence services for pharma companies.
Business Model: unknown
Revenue: 5M
Employees: 78
Industry: Biopharma
Biomedica is a research and development company that fosters the development of critical technologies. Its research program began in 1999 with a partnership set up to bridge the funding gap that exists between science and business. The partnership included leading scientists in the field of fibrinogen biochemistry, immunology, polymer chemistry, and trauma surgery. Biomedica Management Corporation is a clinical-stage federally funded research and development company. The company operates under an innovative business model that fosters the development of critical technologies with the vision of academic scientists. Biomedica brings to the market affordable and effective technologies targeting unmet needs in coagulopathic-related conditions, inflammation, and wound healing. Biomedica is headquartered at the UMBC TechCenter in Baltimore, Maryland.,
Business Model: unknown
Revenue: 7.5M
Employees: 37
Industry: Biopharma
Santarus is a biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products.
Business Model: unknown
Revenue: 337.8M
Employees: 91
Industry: Biopharma
IPM.ai is a Massachusetts-based AI analytics platform that provides patient profiling and HCP advertising solutions for the healthcare sector.
Business Model: unknown
Revenue: 6.8M
Employees: 35
Industry: Biopharma
Premliv Pharmaceuticals is a global R&a;D and contract manufacturing company specializing in nanotechnology-based drugs and biopharmaceuticals. It has extensive expertise in nano-encapsulation, proprietary nanodrug formulation development, liposome preparation and manufacturing, and production of difficult-to-manufacture specialised biopharmaceuticals such as small drug molecules, genetically modified cells and biotech recombinant protein The state-of-the-art nanotechnology drug-delivery-system designed by Premliv&s;s founder is a game-changer in the advanced pharmaceutical industry, enabling for more rapid, effective, and efficient delivery of drug active ingredients to the targeted area of the body.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1001 - 5000
Industry: Biopharma
CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company&s;s strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Chiltern is a contract research organization that provides clinical development services for diagnostics, pharmaceuticals and biotechnology industries.
Business Model: unknown
Revenue: 600M
Employees: 4.5k
Industry: Biopharma
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments. Their products and technologies are designed to harness the power of the immune system, the target-specific cellular mechanism which evolved in vertebrates during the last 450 million years, towards a permanent elimination of pathogens. After 5 years of pioneering research and development in this field, they created a new technology platform which can generate autologous and allogeneic cellular immune therapies for clinical applications: DOT-Cells®.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases. The company was founded by a world-class executive team with extensive experience in the development and commercialization of CVM disease therapies.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
HSE is an engineering service provider in the field of life science and diagnostics industry. HSE was founded in 2016 and was headquartered in Hombrechtikon, Switzerland.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Business Model: unknown
Revenue: 40.5M
Employees: 120
Industry: Biopharma
JB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation. It has also completed a Phase II clinical study in chronic refractory neuropathic pain. JBT-101 is currently being developed as a potential disease modifying treatment for osteoarthritis. JBT-101 also represents a platform for combination with other anti-inflammatory and analgesic agents as well as various drug delivery strategies including ointment and gels, topical patches, and timed release formulations.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Microbia an industrial biotechnology company, engages in the development, production, and commercialization of specialty ingredients and biomaterials utilizing fermentation technology. Its products include carotenoids, specialty ingredients, biopolymers, and other biomaterials. The company has a strategic alliance with Tate &a; Lyle Investments, Ltd. to develop and commercialize fermentation-derived renewable ingredients.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
InVitro Cell Research is dedicated to discovering and developing interventions to slow and reverse biological aging and prevent major age-related diseases. ICR has a small-group vibe and a highly collaborative work environment. They invest in their scientists, providing them the state-of-the-art resources they need to leverage their time and skills most effectively, empowering small teams to accomplish the amazing and advanced their mission.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Parkinson&s;s and Alzheimer’s disease, spinal cord injury, multiple sclerosis, type-2 diabetes, melanoma, pancreatic and breast cancers, among others. By selectively targeting NLRP3, the body’s first line response in the innate immune system, Olatec’s lead compound, dapansutrile (lab code: OLT1177®) inhibits the production of pro-inflammatory cytokines IL 1B and IL 18 Olatec’s drug development team, working together over 10 years, is comprised of experienced management and international thought leaders that have unparalleled expertise in inflammation and immunology and have been involved in the discovery and development of first-line inflammation treatments in the market today. The Company conducts operations in the United States and Europe and maintains offices in New York and the Netherlands.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
iCardiac is a core laboratory for cardiac safety and respiratory services.
Business Model: unknown
Revenue: 19M
Employees: 144
Industry: Biopharma
PharMEDium is a provider of pharmacy compounding services to hospitals.
Business Model: unknown
Revenue: 15.7M
Employees: 122
Industry: Biopharma
Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Biolabs is a Massachusetts-based company that owns and operates co-working spaces for the life sciences sector.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Biopharma
Advanced Life Sciences is a company that discovers, develops and sells Biopharmaceuticals that fight infection, cancer and respiratory diseases.
Business Model: unknown
Revenue: 15.6M
Employees: 59
Industry: Biopharma
We’re here to support Life Science companies to improve quality management, processes, and product development through our all-in-one, pre-validated, and entirely cloud-based SaaS platform. Our vision? To boost science and be Life Sciences allies. We help companies ace audits, improve all processes (not just quality related ones) and save time in the journey toward competitivity in the space. Shape your Scilife: The Scilife platform is a versatile tool capable of managing the diverse lifecycle stages in Life Sciences companies. It’s purpose-built and fully validated according to GAMP5 and 21CFR11 to comply with the rigorous demands and compliance regulations that pharma, biotech, medical devices and ATMP companies face.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform.
Business Model: unknown
Revenue: 0 - 100000
Employees: 51 - 200
Industry: Biopharma
KBiobox engaged in providing genomic analysis services.
Business Model: unknown
Revenue: 587.2k
Employees: 4
Industry: Biopharma
Aptiv Solutions is a global biopharmaceutical and medical device development company.
Business Model: unknown
Revenue: 200M
Employees: 143
Industry: Biopharma
GenVec is a biopharmaceutical company that develops and builds a pipeline of therapeutics and vaccines for gene-based diseases.
Business Model: unknown
Revenue: 335k
Employees: 30
Industry: Biopharma
China Immunotech is a small molecule innovative drug R&a;D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists.
Business Model: unknown
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Biopharma
Vitalgen is a biopharmaceutical company that focuses on the research and development of gene therapeutics. The company is committed to transforming cutting-edge gene and cell therapy technologies into clinically accessible treatments, with the hope of benefiting more many patients. It utilizes CRISPR gene-editing technology to research and develop revolutionary gene therapy to significantly improve the quality of life of patients. Vitalgen was founded in 2020 and is headquartered in Shanghai, China.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Hillstream BioPharma is a New Jersey-based clinical-stage biotechnology firm that develops novel therapeutics for the treatment of cancer.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1
Industry: Biopharma
Brio Bliss is a pharmaceutical company that develops and distributes prescribed drugs.
Business Model: unknown
Revenue: 3.9M
Employees: 21
Industry: Biopharma
Biomeb is a biotechnology company that provide personalized medicine for prevention, diagnosis and treatment of different pathologies. The company is a spin-off of the University of Lleida, whose mission is to provide personalized medicine, providing new products and services to society. Since its creation, BIOMEB has been dedicated to developing the proof of concepts and clinical studies necessaries to bring their first products: Well B®, Fit B® and FIBRACEP® to the market.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma
Pevesa is a manufacturer of protein isolates, hydrolysates, peptides and amino acids for cosmetics, bioscience and food industries.
Business Model: unknown
Revenue: 8.5M
Employees: 41
Industry: Biopharma
We develop bespoke biomarker tests to identify patients and demonstrate treatment efficacy for novel therapeutics. Our tests support pharmaceutical companies in running successful clinical trials and in maximising access to marketed therapies.
Business Model: unknown
Revenue: 5M
Employees: 20
Industry: Biopharma
Drais Pharmaceuticals is a New Jersey-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of unmet diseases.
Business Model: unknown
Revenue: 3M
Employees: 8
Industry: Biopharma
Platinum BioSciences offers pharmacist-compounded nutraceutical products infused with THC-free cannabidiol (CBD), enhanced with scientifically specific terpenes to deliver optimal results in the health and wellness line of products. Platinum Biosciences’ line of CBD infused nutraceutical products have been developed for discriminating customers who are looking for the best product quality and efficacy that nature and science can offer. Platinum BioSciences formulates and produces the highest quality CBD-infused nutraceuticals available. Platinum BioSciences’ products begin with industry proven formulations and they enhance the efficacy of these existing product formulations using known and proven nutraceutical ingredients, and they also add terpene-enriched CBD to potentiate the overall success of their finished products. The company is headquartered in Prosper, Texas, United States.
Business Model: unknown
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Biopharma